<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Npj Ment Health Res</journal-id><journal-id journal-id-type="iso-abbrev">Npj Ment Health Res</journal-id><journal-title-group><journal-title>NPJ Mental Health Research</journal-title></journal-title-group><issn pub-type="epub">2731-4251</issn><publisher><publisher-name>Nature Publishing Group UK</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">38609506</article-id><article-id pub-id-type="pmc">PMC10955936</article-id>
<article-id pub-id-type="publisher-id">12</article-id><article-id pub-id-type="doi">10.1038/s44184-022-00012-9</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Catatonia in autism and other neurodevelopmental disabilities: a state-of-the-art review</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Moore</surname><given-names>Shavon</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Amatya</surname><given-names>Debha N.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Chu</surname><given-names>Michael M.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff4">4</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8671-1203</contrib-id><name><surname>Besterman</surname><given-names>Aaron D.</given-names></name><address><email>abesterman@health.ucsd.edu</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff6">6</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/0168r3w48</institution-id><institution-id institution-id-type="GRID">grid.266100.3</institution-id><institution-id institution-id-type="ISNI">0000 0001 2107 4242</institution-id><institution>University of California San Diego, Department of Psychiatry, </institution></institution-wrap>San Diego, CA USA </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00414dg76</institution-id><institution-id institution-id-type="GRID">grid.286440.c</institution-id><institution-id institution-id-type="ISNI">0000 0004 0383 2910</institution-id><institution>Rady Children&#x02019;s Hospital San Diego, Division of Behavioral Health Services, </institution></institution-wrap>San Diego, CA USA </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/046rm7j60</institution-id><institution-id institution-id-type="GRID">grid.19006.3e</institution-id><institution-id institution-id-type="ISNI">0000 0000 9632 6718</institution-id><institution>UCLA Semel Institute of Neuroscience and Human Behavior, </institution></institution-wrap>Los Angeles, CA USA </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/0282qcz50</institution-id><institution-id institution-id-type="GRID">grid.414164.2</institution-id><institution-id institution-id-type="ISNI">0000 0004 0442 4003</institution-id><institution>Children&#x02019;s Hospital of Orange County, Division of Child and Adolescent Psychiatry, </institution></institution-wrap>Orange, CA USA </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04gyf1771</institution-id><institution-id institution-id-type="GRID">grid.266093.8</institution-id><institution-id institution-id-type="ISNI">0000 0001 0668 7243</institution-id><institution>University of California Irvine, Department of Psychiatry, </institution></institution-wrap>Irvine, CA USA </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00414dg76</institution-id><institution-id institution-id-type="GRID">grid.286440.c</institution-id><institution-id institution-id-type="ISNI">0000 0004 0383 2910</institution-id><institution>Rady Children&#x02019;s Institute for Genomic Medicine, </institution></institution-wrap>San Diego, CA USA </aff></contrib-group><pub-date pub-type="epub"><day>14</day><month>9</month><year>2022</year></pub-date><pub-date pub-type="pmc-release"><day>14</day><month>9</month><year>2022</year></pub-date><pub-date pub-type="collection"><year>2022</year></pub-date><volume>1</volume><elocation-id>12</elocation-id><history><date date-type="received"><day>31</day><month>5</month><year>2022</year></date><date date-type="accepted"><day>26</day><month>8</month><year>2022</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2022</copyright-statement><copyright-year>2022</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article&#x02019;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#x02019;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">Individuals with neurodevelopmental disabilities (NDDs) may be at increased risk for catatonia, which can be an especially challenging condition to diagnose and treat. There may be symptom overlap between catatonia and NDD-associated behaviors, such as stereotypies. The diagnosis of catatonia should perhaps be adjusted to address symptom overlap and to include extreme behaviors observed in patients with NDDs, such as severe self-injury. Risk factors for catatonia in individuals with NDDs may include trauma and certain genetic variants, such as those that disrupt <italic>SHANK3</italic>. Common etiologic features between neurodevelopmental disabilities and catatonia, such as excitatory/inhibitory imbalance and neuroimmune dysfunction, may partially account for comorbidity. New approaches leveraging genetic testing and neuroimmunologic evaluation may allow for more precise diagnoses and effective treatments.</p></abstract><kwd-group kwd-group-type="npg-subject"><title>Subject terms</title><kwd>Human behaviour</kwd><kwd>Autism spectrum disorders</kwd><kwd>Clinical genetics</kwd><kwd>Immunopathogenesis</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer Nature Limited 2022</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p id="Par2">Catatonia is defined as &#x0201c;&#x02026;a marked decrease in reactivity to the environment&#x0201d; characterized by symptoms of negativism, mutism, stupor, excitement, repeated stereotyped movements, staring, and grimacing<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>. It can be a severely debilitating disorder and may occur at elevated rates in patients with neurodevelopmental disabilities (NDDs), such as autism spectrum disorders (ASD), developmental delay (DD), and intellectual disability (ID)<sup><xref ref-type="bibr" rid="CR2">2</xref></sup>. Current prevalence estimates of catatonia in NDDs vary widely from 6 to 20.2%<sup><xref ref-type="bibr" rid="CR3">3</xref>&#x02013;<xref ref-type="bibr" rid="CR6">6</xref></sup>. Likewise, prevalence estimates in neurotypical patients vary widely depending on study design (e.g., prospective vs retrospective), location of the study (e.g., country), recruitment site (e.g., medical or psychiatric hospital or community) and psychiatric or neurologic comorbidities. In a recent meta-analysis of neurotypical clinical samples, the mean prevalence of 74 studies was 9% with a range of 1.9&#x02013;48.5%<sup><xref ref-type="bibr" rid="CR7">7</xref></sup>. Given the wide range prevalence estimates for both populations, it remains uncertain if catatonia is more or less common in patients with NDDs than in neurotypical populations. However, anecdotally catatonia is being increasingly recognized by clinicians who work with patients with NDDs and publication trends on the topic reflect that (Fig. <xref rid="Fig1" ref-type="fig">1</xref>). This increased recognition led to catatonia being added as a modifier to ASD in Diagnostic and Statistical Manual 5<sup><xref ref-type="bibr" rid="CR8">8</xref></sup>. So while it remains unconfirmed if individuals with NDDs have an elevated rates of catatonia, it is critical that we further our understanding of how neurobiological processes associated with NDDs may lead to a susceptibility to catatonia and what that might imply about how best to assess, diagnose, and treat catatonia in individuals with NDDs.<fig id="Fig1"><label>Fig. 1</label><caption><title>A recent increase in publications on catatonia in patients with NDDs.</title><p>Data obtained from Timeline feature on <ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/">https://pubmed.ncbi.nlm.nih.gov/</ext-link> after searching &#x0201c;catatonia&#x0201d; and (&#x0201c;intellectual disability&#x0201d; or &#x0201c;developmental delay&#x0201d; or &#x0201c;autism&#x0201d; or &#x0201c;neurodevelopmental disorders&#x0201d;) on February 14, 2022.</p></caption><graphic xlink:href="44184_2022_12_Fig1_HTML" id="d33e274"/></fig></p><p id="Par3">Many reports of patients with NDDs and catatonia discuss ASD or &#x0201c;autistic catatonia&#x0201d; specifically<sup><xref ref-type="bibr" rid="CR9">9</xref>,<xref ref-type="bibr" rid="CR10">10</xref></sup>. However, on close examination of these cases, many have complex neurodevelopmental presentations, often with low levels of premorbid functioning, suggestive of comorbid DD and/or ID in addition to ASD<sup><xref ref-type="bibr" rid="CR11">11</xref></sup> (Table <xref rid="Tab1" ref-type="table">1</xref>). This entangling of NDD diagnoses makes it difficult to know if atypical neurodevelopment in the broadest sense, as compared to ASD-specific pathophysiology, may predispose individuals to catatonia.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Summary of representative published cases of patients with NDDs and catatonia.</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Reference</th><th>Age (years)</th><th>Symptoms</th><th>Trauma</th><th>Rating scale used</th><th>ASD</th><th>ID</th><th>Comorbidities</th><th>Genetic testing completed</th><th>ECT (sessions)</th><th>Maintenance ECT (months)</th></tr></thead><tbody><tr><td><sup><xref ref-type="bibr" rid="CR106">106</xref></sup></td><td>6</td><td>Mutism, appetite changes, withdrawal</td><td>+</td><td>&#x02212;</td><td>+</td><td>&#x02212;</td><td>ADHD</td><td>+&#x02009;</td><td/><td>&#x02212;</td></tr><tr><td><sup><xref ref-type="bibr" rid="CR107">107</xref></sup></td><td>16</td><td>Withdrawal, mutism, regression, appetite changes, stupor, posturing</td><td>+</td><td>&#x02212;</td><td>+</td><td>&#x02212;</td><td>&#x02212;</td><td>&#x02212;</td><td>+</td><td>+ (6)</td></tr><tr><td><sup><xref ref-type="bibr" rid="CR107">107</xref></sup></td><td>13</td><td>Stupor, grimacing, waxy flexibility, agitation,</td><td>+</td><td>&#x02212;</td><td>+</td><td>+</td><td>&#x02212;</td><td>+</td><td>+ (12)</td><td>&#x02212;</td></tr><tr><td><sup><xref ref-type="bibr" rid="CR9">9</xref></sup></td><td>15</td><td>Mutism, appetite changes, waxy flexibility, posturing, withdrawal</td><td>&#x02212;</td><td>&#x02212;</td><td>+</td><td>+</td><td>&#x02212;</td><td>&#x02212;</td><td>+ (-)</td><td>+ (-)</td></tr><tr><td><sup><xref ref-type="bibr" rid="CR9">9</xref></sup></td><td>14</td><td>Stupor, posturing, waxy flexibility, echolalia, mutism, appetite changes, autonomic dysfunction</td><td>&#x02212;</td><td>&#x02212;</td><td>+</td><td>+</td><td>&#x02212;</td><td>&#x02212;</td><td>+ (12)</td><td>&#x02212;</td></tr><tr><td><sup><xref ref-type="bibr" rid="CR9">9</xref></sup></td><td>17</td><td>Self-injury, negativism, posturing, echolalia, echopraxia, Mutism</td><td>&#x02212;</td><td>&#x02212;</td><td>+</td><td>+</td><td>&#x02212;</td><td>&#x02212;</td><td>+</td><td>+ (-)</td></tr><tr><td><sup><xref ref-type="bibr" rid="CR108">108</xref></sup></td><td>13</td><td>Catatonia, negativism, immobility, echolalia, posturing, and rigidity</td><td>&#x02212;</td><td>&#x02212;</td><td>+</td><td>&#x02212;</td><td>&#x02212;</td><td>&#x02212;</td><td>&#x02212;</td><td>&#x02212;</td></tr><tr><td><sup><xref ref-type="bibr" rid="CR16">16</xref></sup></td><td>11</td><td>Mutism, rigidity, posturing, waxy flexibility, appetite, regression</td><td>+</td><td>+</td><td>+</td><td>&#x02212;</td><td>&#x02212;</td><td>&#x02212;</td><td>&#x02212;</td><td>&#x02212;</td></tr><tr><td><sup><xref ref-type="bibr" rid="CR109">109</xref></sup></td><td>18</td><td>Self-injury, withdrawal, rigidity, staring, mutism, appetite changes, posturing</td><td>&#x02212;</td><td>&#x02212;</td><td>+</td><td>+</td><td>TS</td><td>+&#x02009;</td><td>+ (12)</td><td>+ (13)</td></tr><tr><td><sup><xref ref-type="bibr" rid="CR101">101</xref></sup></td><td>8</td><td>Self-injury, stereotypy, agitation</td><td>&#x02212;</td><td>&#x02212;</td><td>+</td><td>+</td><td>&#x02212;</td><td>&#x02212;</td><td>+</td><td>&#x02212;</td></tr><tr><td><sup><xref ref-type="bibr" rid="CR110">110</xref></sup></td><td>14</td><td>Posturing, rigidity, waxy flexibility, regression, appetite changes, mutism, staring, autonomic instability</td><td>&#x02212;</td><td>&#x02212;</td><td>+</td><td>+</td><td>&#x02212;</td><td>&#x02212;</td><td>+ (12)</td><td>+</td></tr><tr><td><sup><xref ref-type="bibr" rid="CR111">111</xref></sup></td><td>16</td><td>Agitation, echolalia self-injury, stupor, posturing</td><td>&#x02212;</td><td>&#x02212;</td><td>+</td><td>&#x02212;</td><td>CVID, VWD</td><td>&#x02212;</td><td>+ (29)</td><td>+</td></tr><tr><td><sup><xref ref-type="bibr" rid="CR111">111</xref></sup></td><td>15</td><td>Agitation, self-injury, echolalia, stereotypy</td><td>&#x02212;</td><td>&#x02212;</td><td>+</td><td>+</td><td>MC, POS</td><td>&#x02212;</td><td>+ (48)</td><td>+ (57)</td></tr></tbody></table><table-wrap-foot><p>+ = reported; &#x02212; = not reported or unknown, <italic>ASD</italic> autism spectrum disorder, <italic>ADHD</italic> attention deficit hyperactivity disorder, <italic>CVID</italic> Common variable immune deficiency, <italic>ECT</italic> electroconvulsive therapy, <italic>ID</italic> intellectual disability, <italic>MC</italic> macrocephaly, <italic>POS</italic> polycystic ovary syndrome, <italic>TS</italic> Tourette syndrome, <italic>VWD</italic> Von Willebrand disease.</p></table-wrap-foot></table-wrap></p><p id="Par4">For the purposes of this review, we highlight key points using ASD as an example, with the same principles likely applying across NDDs. We describe what is known about catatonia in NDDs, discuss underlying neurobiological factors, and explore the complicated clinical and nosological overlap of catatonia with NDDs. Finally, we propose an assessment and management approach and suggest potential future strategies to improve the understanding and treatment of catatonia in patients with NDDs. While catatonia in ASD and NDDs has been reviewed numerous times before<sup><xref ref-type="bibr" rid="CR12">12</xref>&#x02013;<xref ref-type="bibr" rid="CR17">17</xref></sup>, we hope that this review adds an integrative, biologically- and evidence-based, &#x0201c;state-of-the-art&#x0201d; perspective. We highlight what we believe are the greatest needs of future research on this topic and hope to set the field on an evidence-based path forward to improve assessment, diagnosis, and treatment of patients with catatonia and NDDs.</p></sec><sec id="Sec2"><title>Methods</title><p id="Par5">We searched PubMed and Google Scholar using the terms: &#x0201c;catatonia&#x0201d; and (&#x0201c;intellectual disability&#x0201d; or &#x0201c;developmental delay&#x0201d; or &#x0201c;autism&#x0201d; or &#x0201c;neurodevelopmental disorders&#x0201d;) on February 14, 2022. We subsequently checked reference lists of articles and reviews until we were no longer identifying new sources. Literature published in English was selected for relevance to the topics of this Review (e.g., history, epidemiology, clinical features, treatment).</p></sec><sec id="Sec3" sec-type="results"><title>Results</title><sec id="Sec4"><title>History</title><p id="Par6">In the study of developmental psychopathology, there has long been a debate about the proper classification of certain overlapping classes of symptoms&#x02014;catatonic, autistic, and psychotic&#x02014;dubbed &#x0201c;the iron triangle&#x0201d;<sup><xref ref-type="bibr" rid="CR18">18</xref></sup>. Early physicians had different approaches to classifying patients with a mix of psychomotor symptoms, deficits in social and language skills, and psychotic symptoms. For example, in the early 20th century the term &#x0201c;childhood schizophrenia&#x0201d; was widely used to describe a wide range of patients with a mix of these symptoms, to the point that it became so non-specific that Sir Michael Rutter urged the term to be fully retired to &#x0201c;the history of psychiatry&#x0201d; in 1972<sup><xref ref-type="bibr" rid="CR19">19</xref></sup>. He similarly argued for the separation of a disorder fully distinct from psychosis or schizophrenia termed autism or &#x0201c;infantile autism&#x0201d;, characterized by &#x0201c;failure of social development (of a specific type), a deviant and delayed language development, and various ritualistic activities&#x0201d;<sup><xref ref-type="bibr" rid="CR19">19</xref></sup>. Karl Leonhard took a different approach to categorizing symptoms of &#x0201c;&#x02026;stereotypies, impulsive-aggressive, self-injurious and disruptive behaviors, lack of expression, negativism, excitement, ambivalence, counter-grasping, mannerisms, peculiar speech patterns including echolalia, and neologisms&#x02026;&#x0201d;. He classified these symptoms as &#x0201c;early childhood catatonia&#x0201d;, a subtype of &#x0201c;psychomotor psychoses&#x0201d;<sup><xref ref-type="bibr" rid="CR20">20</xref></sup>. This alternative formulation through the lense of catatonia, as opposed to autism, is reflective of the overlapping symptamotolgy between these disorders. Nearly a century later, there are clearer distinction between what constitutes psychosis, autism, and catatonia, but there are certainly cases where it remains challenging to understand if new psychomotor or negativistic symptoms represent an exacerbation of preexisting neuropsychiatric symptoms or comorbid catatonia in patients with NDDs<sup><xref ref-type="bibr" rid="CR6">6</xref></sup>. Thankfully, there is increasing recognition of the comorbidity between catatonia and NDDs<sup><xref ref-type="bibr" rid="CR21">21</xref></sup> and a growing body of literature on overlap of these conditions (Fig. <xref rid="Fig1" ref-type="fig">1</xref>).</p></sec><sec id="Sec5"><title>Phenomenology</title><p id="Par7">&#x0201c;Classic&#x0201d; catatonia can be observed in patients with NDDs and may at times be straightforward to recognize and treat. However, there is often significant overlap in symptomatology between catatonic symptoms and some behaviors commonly seen in patients with NDDs. These include motor stereotypies, mannerisms, rituals, mutism, echolalia, and negativism<sup><xref ref-type="bibr" rid="CR10">10</xref></sup>, which can make it challenging to distinguish an exacerbation of previous behaviors from catatonia. It is also unclear if the definition of catatonia in patients with NDDs should be altered to incorporate their neurodiversity. For example, it has been suggested that &#x0201c;autistic catatonia&#x0201d; may be best defined by freezing when carrying out actions, resistance to prompting, slow voluntary motor movements, and stopping in the course of movement<sup><xref ref-type="bibr" rid="CR22">22</xref></sup>. However, this definition may capture behaviors nonspecific to catatonia and lead to overdiagnosis. It has also been suggested that extreme behaviors such as severe self-injury or unremitting tics may be uniquely indicative of catatonia in individuals with NDDs<sup><xref ref-type="bibr" rid="CR14">14</xref>,<xref ref-type="bibr" rid="CR23">23</xref></sup>. These behaviors can result in severe morbidity and impairment, and can be refractory to standard treatments, and are sometimes responsive to catatonia treatments like benzodiazepines and electroconvulsive therapy (ECT)<sup><xref ref-type="bibr" rid="CR14">14</xref></sup> However, it remains to be demonstrated whether these behaviors represent their own clinical entity or are part of the catatonia continuum for patients with NDDs. Currently, only clinical reports (and not rigorous field trials) support these behaviors as part of the catatonia syndrome in patients with NDDs, which creates the risk of confirmation and reporting bias<sup><xref ref-type="bibr" rid="CR24">24</xref>,<xref ref-type="bibr" rid="CR25">25</xref></sup>. Therefore, a rigorous assessment of the validity and reliability of expanded criteria for catatonia in NDDs is warranted.</p></sec><sec id="Sec6"><title>Trauma</title><p id="Par8">Trauma has long been recognized as a potential risk factor for catatonia or catatonia-like states<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>. For example, freeze responses are observed in individuals with post-traumatic stress disorders, victims of violent assault, and those who have experienced urban violence, environmental disasters, and military combat and may represent a primitive human response to imminent doom and danger<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>. Likewise, a catatonic-like response to trauma and stress, defined by significant reduction in oral intake, communication, movement, and self-care, termed &#x0201c;Pervasive Refusal Disorder&#x0201d; has been described in neurotypical patients of asylum-seeking families<sup><xref ref-type="bibr" rid="CR28">28</xref></sup>. It remains controversial whether this disorder is nosologically separate from catatonia<sup><xref ref-type="bibr" rid="CR29">29</xref></sup>.</p><p id="Par9">In patients with NDDs who may be exquisitely sensitive to their environment, disruptions to important daily routines or losses of important life figures can be highly distressing, even traumatic, and potentially triggering of catatonia. In an early study (using a very broad definition of catatonia), 2.5% of patients with NDDs and catatonia had precipitating stressors such as grief, pressures at school, and loss of structure after the environmental change (Wing &#x00026; Shah, 2000). The true rate of trauma precipitating catatonia is likely higher, based on recent clinical experience and published reports (Table <xref rid="Tab1" ref-type="table">1</xref>). Other traumatic experiences, such as physical abuse and parental divorce, have been associated with the emergence of catatonic symptoms in patients with ASD<sup><xref ref-type="bibr" rid="CR12">12</xref>,<xref ref-type="bibr" rid="CR26">26</xref></sup>. Although there are no current guidelines regarding the evaluation of trauma in catatonia, it may be worth considering screening patients with NDDs presenting with catatonic symptoms for recent stressors or traumas to aid diagnosis and potentially guide treatment (Fig. <xref rid="Fig2" ref-type="fig">2</xref>). Addressing the trauma through behavioral or other psychotherapeutic approaches may ameliorate catatonic symptoms, but that is yet to be rigorously assessed.<fig id="Fig2"><label>Fig. 2</label><caption><title>Proposed evaluation and treatment of catatonia in patients with NDDs.</title><p>BFCRS Bush-Francis catatonia rating scale, ECT electroconvulsive therapy, IEM inborn error of metabolism, PCRS Pediatric catatonia rating scale, Green circles represent entry points, Red circles represent exit points, Yellow diamonds represent decision points, White boxes represent established processes, Blue boxes represent processes novel to our algorithm, &#x0201c;?&#x0201d; represents a potentially informative approach to consider but without sufficient data to fully support implementation.</p></caption><graphic xlink:href="44184_2022_12_Fig2_HTML" id="d33e822"/></fig></p></sec><sec id="Sec7"><title>Assessment</title><p id="Par10">The heterogeneous nature of catatonia and the overlapping symptomatology with NDDs makes it challenging to create a universally generalizable and valid standardized assessment tool for all patient populations. As a results, several catatonia rating scales have been shown to have fairly low specificity<sup><xref ref-type="bibr" rid="CR30">30</xref></sup>. The Bush-Francis Catatonia Rating Scale (BFCRS) is the most widely used validated catatonia rating scale in neurotypical adults and has been used in patients with NDDs as well<sup><xref ref-type="bibr" rid="CR31">31</xref></sup>. An adaptation of the BFCRS, the Pediatric Catatonia Rating Scale (PCRS), is validated for pediatric patients in the inpatient setting that captures most of the same features as the BFCRS, with the exception of hyperactivity/excitement<sup><xref ref-type="bibr" rid="CR32">32</xref></sup>. The Attenuated Behavior Questionnaire (ABQ)<sup><xref ref-type="bibr" rid="CR33">33</xref></sup> was developed to specifically capture the &#x0201c;autistic catatonia&#x0201d; syndrome in the outpatient setting that was previously described<sup><xref ref-type="bibr" rid="CR3">3</xref></sup>. It is a 34-item, questionnaire that can be administered to caregivers of patients with ASD that has some discriminant validity for catatonia in this population<sup><xref ref-type="bibr" rid="CR33">33</xref></sup>. However, the ABQ may over-estimate the prevalence of catatonia in this population (up to 48% in the original study) and likely has low specificity, given ABQ scores are positively correlated with measures of depression and repetitive/restrictive behaviors<sup><xref ref-type="bibr" rid="CR33">33</xref></sup>. Therefore, the BFCRS and PCRS remain the most reliable scales to assess for catatonia in adult and pediatric patients with NDDs, respectively, and their regular implementation may help improve the consistency of future studies to improve comparability (Fig. <xref rid="Fig2" ref-type="fig">2</xref>).</p></sec><sec id="Sec8"><title>Pathophysiology</title><p id="Par11">The etiology of catatonia remains poorly understood<sup><xref ref-type="bibr" rid="CR34">34</xref></sup>. However, the potentially elevated rates of catatonia in patients with NDDs and especially the overlapping symptomatology of catatonia and ASD, such as repetitive behaviors, stereotypic speech, and mannerisms, suggest that there may be common biological mechanisms underlying these conditions. Biological convergence could occur at multiple levels, including the genetic level, the neural circuit level, and/or the neuroimmune interface level (Table <xref rid="Tab2" ref-type="table">2</xref>). Improving our understanding of the neurobiological overlap between NDDs and catatonia on these different scales may help us make sense of the diversity of catatonia presentations in patients with NDDs.<table-wrap id="Tab2"><label>Table 2</label><caption><p>Examples of potential convergent biological mechanisms in catatonia and NDDs.</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Level</th><th>Mechanism</th><th>Catatonia</th><th>NDDs</th></tr></thead><tbody><tr><td rowspan="2">Genetic</td><td>Noncoding single nucleotide variants</td><td>&#x02022;&#x02009;Small nucleolar RNA mutations are hypothesized to impact downstream gene regulation &#x00026; splicing in catatonia<sup><xref ref-type="bibr" rid="CR45">45</xref></sup></td><td>&#x02022;&#x02009;Mouse models with small nucleolar RNA deletions recapitulate symptoms of autism<sup><xref ref-type="bibr" rid="CR46">46</xref></sup></td></tr><tr><td>Structural variants</td><td>&#x02022;&#x02009;22q13.3 and 22q11.2 deletions are associated with catatonia<sup><xref ref-type="bibr" rid="CR39">39</xref></sup></td><td>&#x02022;&#x02009;Disruption of 22q13.3 and 22q11.2 deletions associated with NDDs<sup><xref ref-type="bibr" rid="CR112">112</xref></sup></td></tr><tr><td>Neural circuits</td><td>EI imbalance</td><td>&#x02022;&#x02009;Local glutamate overactivity and GABA underactivity is thought to play a role in catatonia<sup><xref ref-type="bibr" rid="CR34">34</xref>,<xref ref-type="bibr" rid="CR52">52</xref></sup></td><td><p>&#x02022;&#x02009;Mouse models support disruption in EI balance leading to ASD phenotypes. Increasing EI balance in prefrontal cortex using optogenetics leads to social deficits<sup><xref ref-type="bibr" rid="CR61">61</xref>,<xref ref-type="bibr" rid="CR62">62</xref></sup></p><p>&#x02022;&#x02009;Decreased GABA receptor density and altered GAD1 and GAD2 levels. Functional imaging studies identify local hyperconnectivity and decreased long-range connections<sup><xref ref-type="bibr" rid="CR60">60</xref></sup></p></td></tr><tr><td>Neuroimmune interface</td><td>Autoimmunity</td><td><p>&#x02022;&#x02009;NMDAR encephalitis is causally linked to the development of catatonia<sup><xref ref-type="bibr" rid="CR52">52</xref></sup></p><p>&#x02022;&#x02009;Systemic autoimmune conditions, like SLE, increase risk for the development of catatonia<sup><xref ref-type="bibr" rid="CR113">113</xref></sup></p><p>&#x02022;&#x02009;Rodent models suggest that brain inflammation in catatonia is mediated by microglial activation<sup><xref ref-type="bibr" rid="CR37">37</xref></sup></p><p>&#x02022;&#x02009;Standard treatments for catatonia, like ECT, have been shown to have an immunomodulatory effect over chronic administration<sup><xref ref-type="bibr" rid="CR71">71</xref></sup></p></td><td><p>&#x02022;&#x02009;Family history of autoimmune conditions increase the risk for ASD<sup><xref ref-type="bibr" rid="CR65">65</xref></sup></p><p>&#x02022;&#x02009;Gene network analysis identify immune dysregulation and microglial activation as key molecular signatures<sup><xref ref-type="bibr" rid="CR77">77</xref></sup></p><p>&#x02022;&#x02009;Rodent models suggest that attenuation of microglial activity can rescue ASD-like behaviors<sup><xref ref-type="bibr" rid="CR37">37</xref></sup></p></td></tr></tbody></table><table-wrap-foot><p><italic>ASD</italic> autism spectrum disorder, <italic>EI</italic> excitatory/inhibitory, <italic>NMDAR</italic> NMDA receptor, <italic>NDDs</italic> neurodevelopmental disabilities, <italic>SLE</italic> systemic lupus erythematosus.</p></table-wrap-foot></table-wrap></p><p id="Par12">The degree of familial aggregation<sup><xref ref-type="bibr" rid="CR35">35</xref></sup> of catatonia (e.g., the degree to which catatonia phenotypes tend to cluster in families that cannot be accounted for by chance) varies significantly depending on how it is defined, but overall points to a strong genetic contribution<sup><xref ref-type="bibr" rid="CR36">36</xref></sup>. Candidate genes (e.g., genes hypothesized to be associated with a disorder based on their biological function) such as 2&#x02032;,<italic>3</italic>&#x02032;-<italic>cyclic nucleotide 3</italic>&#x02032;-<italic>phosphodiesterase</italic> and <italic>myelin basic protein</italic> have been implicated in catatonia through animal studies of catatonia-like behaviors and correlation of candidate genotypes with catatonia symptoms in patients with schizophrenia<sup><xref ref-type="bibr" rid="CR37">37</xref></sup>. However, there are significant limitations to candidate gene studies in psychiatry<sup><xref ref-type="bibr" rid="CR38">38</xref></sup>, and these associations have not, to our knowledge, been replicated in large-scale population-based genetic studies. Catatonia has been observed in patients with NDDs with established genetic etiologies<sup><xref ref-type="bibr" rid="CR39">39</xref></sup>, such as Prader-Willi syndrome<sup><xref ref-type="bibr" rid="CR40">40</xref></sup>, 22q13.3 deletion syndrome (Phelan-McDermid syndrome)<sup><xref ref-type="bibr" rid="CR41">41</xref></sup>, Down syndrome<sup><xref ref-type="bibr" rid="CR42">42</xref></sup>, 22q11.2 Deletion syndrome<sup><xref ref-type="bibr" rid="CR43">43</xref></sup>, and late-onset Tay-Sachs disease<sup><xref ref-type="bibr" rid="CR44">44</xref></sup>. These rare genetic disorders can shed light on the neurobiological etiology of catatonia. For example, it has been proposed that many of the genetic disorders above have convergent neurobiological disruption of the brain-specific, non-coding micro-RNA, <italic>SNORD115</italic>, that lies in the Prader-Willi/Angelman syndrome region (e.g., 15q11. 2 - q13) and plays a central role in nucleolar function<sup><xref ref-type="bibr" rid="CR45">45</xref>,<xref ref-type="bibr" rid="CR46">46</xref></sup>. SNORD115 is known to regulate the downstream effector genes of Ral GEF With PH Domain And SH3 Binding Motif 1 (<italic>RALPGS1</italic>), which subsequently modulates RAS Like Proto-Oncogenes A and B (RalA and RalB) and their binding proteins<sup><xref ref-type="bibr" rid="CR45">45</xref>,<xref ref-type="bibr" rid="CR47">47</xref></sup>. This may lead to NMDA receptor dysfunction in the postsynaptic density through altered endocytotic and autophagic lysosomal degradation<sup><xref ref-type="bibr" rid="CR45">45</xref></sup>. NMDA receptor dysfunction is likewise hypothesized to underlie catatonia risk associated with <italic>SHANK3</italic>-associated disorders as it leads to alterations in cellular excitability<sup><xref ref-type="bibr" rid="CR45">45</xref>,<xref ref-type="bibr" rid="CR48">48</xref></sup>. There is potential mechanistic overlap with an ASD susceptibility locus linked with catatonia, 15q15-q21, which includes genes responsible for encoding GABA receptors B3, A5, and G3<sup><xref ref-type="bibr" rid="CR49">49</xref>,<xref ref-type="bibr" rid="CR50">50</xref></sup>, again suggesting dysregulated cellular excitability may also be contributory to the pathogenesis of catatonia. This genetic evidence suggests that both catatonia and ASD may be associated with changes in Excitatory-Inhibitory (EI) balance, a circuit level dysfunction that has been observed both in animal models of catatonia and clinical settings<sup><xref ref-type="bibr" rid="CR51">51</xref></sup>.</p><p id="Par13">EI balance has been defined as, &#x0201c;&#x02026;a stable global level of activity within a particular circuit, even though individual groups of neurons may exhibit transient imbalances, and these groups of neurons can be dynamic over time&#x0201d;<sup><xref ref-type="bibr" rid="CR51">51</xref></sup>. A pathological EI imbalance that may be present in catatonia can be mediated through increased excitatory tone by local states of low dopamine, which can trigger excess glutamate release and excitotoxicity<sup><xref ref-type="bibr" rid="CR34">34</xref>,<xref ref-type="bibr" rid="CR52">52</xref></sup>. The interaction between dopamine and catatonia is further strengthened by the observation that dopamine blockade with antipsychotics can exacerbate symptoms of catatonia, and NMDA receptor blockade can conversely relieve symptoms<sup><xref ref-type="bibr" rid="CR11">11</xref></sup>. Similarly, decreased inhibitory tone through GABA hypoactivity may play an important mechanistic role in catatonia<sup><xref ref-type="bibr" rid="CR53">53</xref>,<xref ref-type="bibr" rid="CR54">54</xref></sup> that can be ameliorated through the use of GABA-ergic medications like benzodiazepines and through ECT<sup><xref ref-type="bibr" rid="CR12">12</xref>,<xref ref-type="bibr" rid="CR26">26</xref></sup>. Neuroanatomical correlates of EI dysregulation in catatonia have been studied with neuroimaging. Hypokinetic catatonia has been associated with localized hyperactivity in the supplementary and pre-supplementary motor areas, which are important in the generation and regulation of movement through interaction with the basal ganglia<sup><xref ref-type="bibr" rid="CR11">11</xref>,<xref ref-type="bibr" rid="CR34">34</xref></sup>. GABA concentration specifically within the supplementary motor areas are correlated to individual differences in motor planning, thus emphasizing the role for local EI imbalance within these particular brain structures as a potential important mechanism in catatonia and source of heterogeneity in clinical manifestation<sup><xref ref-type="bibr" rid="CR55">55</xref></sup>.</p><p id="Par14">Similarly, EI imbalance has been implicated in the pathogenesis of ASD<sup><xref ref-type="bibr" rid="CR51">51</xref></sup>. From the integration of post-mortem and genetic analyses, it has been suggested that inhibitory hypofunction is a potential convergent pathway mechanism for the diverse pool of genetic mutations associated with synaptic dysfunction in ASD<sup><xref ref-type="bibr" rid="CR56">56</xref>,<xref ref-type="bibr" rid="CR57">57</xref></sup>. This may manifest as reduced synaptic input into inhibitory neurons, as is the case for variation in ASD-associated genes, <italic>NLGN3</italic> and <italic>MECP2</italic>, or diminished inhibitory output on excitatory circuits, which may occur secondary to <italic>SHANK3</italic> or <italic>TSC1</italic> dysfunction<sup><xref ref-type="bibr" rid="CR58">58</xref>,<xref ref-type="bibr" rid="CR59">59</xref></sup>. Furthermore, reduced GABA receptor density has been observed in individuals with ASD, consistent with a theory of reduced inhibitory tone and subsequent EI imbalance<sup><xref ref-type="bibr" rid="CR60">60</xref></sup>. This finding has been recapitulated in rodent models, where optogenetic modulation of cortical EI precipitates ASD-like social deficits, which are rescued by GABA agonism or NMDA antagonism<sup><xref ref-type="bibr" rid="CR61">61</xref>,<xref ref-type="bibr" rid="CR62">62</xref></sup>. On a clinical and epidemiological level, EI imbalance across brain regions is consistent with the high comorbidity between ASD and epilepsy, a disorder characterized by extreme excess of neural excitation or deficit of inhibition<sup><xref ref-type="bibr" rid="CR63">63</xref></sup>. Therefore, the strong evidence for loss of inhibitory neural circuit tone in both ASD and catatonia may represent a convergent mechanism between the two disorders.</p><p id="Par15">The neuroimmune axis refers to the flow of information between the immune and nervous systems that play a role in both homeostasis and a variety of disease states<sup><xref ref-type="bibr" rid="CR64">64</xref></sup>. Neuroimmune dysfunction, particularly through autoimmune activation, has also been associated with both ASD and catatonia<sup><xref ref-type="bibr" rid="CR65">65</xref>,<xref ref-type="bibr" rid="CR66">66</xref></sup>. For example, autoimmune encephalitis (AIEs) of various etiologies (e.g., Anti-NMDA receptor (NMDAR); Anti-GABA-A receptor) have been observed in patients with catatonia<sup><xref ref-type="bibr" rid="CR67">67</xref>,<xref ref-type="bibr" rid="CR68">68</xref></sup>. Inflammatory physiologic disorders (e.g., systemic lupus erythematosus and thyroid disorders) have also been described in patients with catatonia<sup><xref ref-type="bibr" rid="CR66">66</xref>,<xref ref-type="bibr" rid="CR69">69</xref></sup>. NMDAR encephalitis is the autoimmune disorder most frequently associated with catatonia and serves as a potential link between neuroimmune interactions and EI balance, as discussed above<sup><xref ref-type="bibr" rid="CR66">66</xref></sup>. In NMDAR encephalitis, autoantibodies target subunits on the receptors of excitatory glutamatergic neurons, causing internalization of the receptor, excitatory hypofunction, and a host of neuropsychiatric symptoms, such as psychosis, seizures, impaired cognition, and catatonia<sup><xref ref-type="bibr" rid="CR69">69</xref></sup>. Interestingly, catatonia associated with NMDAR encephalitis has been effectively treated with both benzodiazepines and ECT, suggesting that strong neuromodulation may regulate immune dysfunction<sup><xref ref-type="bibr" rid="CR66">66</xref></sup>. However, the impact of ECT on the neuroimmune system is complex, with some conflicting outcomes and variability depending on the chronicity of treatment and the model used. For example, a transient upregulation of neuroinflammatory cytokines, microglial activation, and an increase in the oxidative stress response are observed following acute ECT in animal models<sup><xref ref-type="bibr" rid="CR70">70</xref></sup>. But in a rodent model of autoimmune encephalomyelitis, electroconvulsive seizures attenuate the innate immune system through reduced activation of T cells by microglia over time<sup><xref ref-type="bibr" rid="CR71">71</xref></sup>. Therefore, repeated ECT treatments may directly counter the pro-inflammatory effects of AIE through modulation of the innate immune system in brain specific immune cell types<sup><xref ref-type="bibr" rid="CR71">71</xref></sup>. These findings highlight the complex relationship between neuroimmunity, neuroinflammation, and the incompletely understood mechanisms of current catatonia treatments.</p><p id="Par16">Similarly, the development of ASD has been linked to both acquired and inherited immune dysregulation<sup><xref ref-type="bibr" rid="CR72">72</xref></sup>. Patients with ASD are more likely to have a family history of autoimmune conditions, such as type 1 diabetes, psoriasis, hypothyroidism, and rheumatoid arthritis<sup><xref ref-type="bibr" rid="CR73">73</xref></sup>. A subset of mothers may pass maternal antibodies to their fetus during prenatal development, which has been linked to macrocephaly and ASD-related traits, such as reduced language expressivity and stereotypic behaviors<sup><xref ref-type="bibr" rid="CR73">73</xref>,<xref ref-type="bibr" rid="CR74">74</xref></sup>. Additionally, a study of monozygotic twins discordant for ASD revealed that the top differentially expressed gene across pairs was <italic>IGHG4</italic>, which codes for a surface protein on B-cells that plays a key role in immune cell activation<sup><xref ref-type="bibr" rid="CR75">75</xref></sup>. This adds to a growing body of literature that demonstrates the importance of immune and inflammatory genes in ASD, such as reduced expression of genes in the complement pathway<sup><xref ref-type="bibr" rid="CR76">76</xref></sup>, identification of gene networks of microglial activation that may impact synaptic transmission<sup><xref ref-type="bibr" rid="CR77">77</xref></sup>, and differential impacts of microglial protein synthesis on synaptic pruning and ASD related behaviors across sexes<sup><xref ref-type="bibr" rid="CR78">78</xref></sup>. Later in life, individuals with ASD are prone to developing comorbid autoimmune conditions at elevated rates, particularly with conditions that affect the nervous system, such as multiple sclerosis, myasthenia gravis, and Guillain-Barr&#x000e9; syndrome<sup><xref ref-type="bibr" rid="CR79">79</xref></sup>. Therefore, immune dysregulation through inherited and acquired factors likely plays a significant role in the pathophysiology of ASD.</p></sec><sec id="Sec9"><title>Diagnosis</title><p id="Par17">Genetic testing and counseling is now recommended in the evaluation of all patients with NDDs (with or without catatonia), because of the high diagnostic yield (~35%) and increasing promise of diagnostic clarity, medical prognosis, and value to the patient and family<sup><xref ref-type="bibr" rid="CR80">80</xref></sup> (Table <xref rid="Tab3" ref-type="table">3</xref>). For catatonia in patients with NDDs, genetic testing can provide additional information about the underlying etiology and even suggest specific treatments if an inborn error of metabolism, like late-onset Tay-Sachs disease<sup><xref ref-type="bibr" rid="CR44">44</xref></sup> or a <italic>SHANK3</italic>-related disorder are detected<sup><xref ref-type="bibr" rid="CR81">81</xref>,<xref ref-type="bibr" rid="CR82">82</xref></sup>. However, standard genetic testing and counseling approaches typically take weeks or months due to limited genetics providers, insurance authorization and the testing process itself. For critically ill patients with debilitating catatonia, this timeline may be insufficient. Rapid genetic testing, notably rapid whole genome sequencing (rWGS), with turnaround times of hours to days, has been shown to improve outcomes and reduce medical expenses for pediatric and neonatal intensive care patients<sup><xref ref-type="bibr" rid="CR83">83</xref></sup>. It may be worth considering for the most emergent cases of catatonia, especially malignant catatonia or severe self-injury (Fig. <xref rid="Fig2" ref-type="fig">2</xref>). For less critical patients, standard genetic testing approaches should include methods that at least detect large genomic deletions and duplications (e.g., chromosomal microarray) and single base pair changes (e.g., exome sequencing) or those that detect both variants together (e.g., WGS), as both variant types have been associated with NDDs and catatonia<sup><xref ref-type="bibr" rid="CR39">39</xref>,<xref ref-type="bibr" rid="CR84">84</xref></sup> (Table <xref rid="Tab3" ref-type="table">3</xref> and Fig. <xref rid="Fig2" ref-type="fig">2</xref>). Appropriate genetic counseling before ordering the tests and returning the results is essential to ensure informed consent/assent and optimal outcomes<sup><xref ref-type="bibr" rid="CR84">84</xref>,<xref ref-type="bibr" rid="CR85">85</xref></sup>.<table-wrap id="Tab3"><label>Table 3</label><caption><p>Genetic testing strategies for neurodevelopmental disabilities.</p></caption><table frame="hsides" rules="groups"><tbody><tr><td><bold>Fragile X testing</bold></td></tr><tr><td> Previously recommended as first-tier test for all males with NDDs, but low yield has resulted in reconsideration of this recommendation (<ext-link ext-link-type="uri" xlink:href="https://www.nature.com/articles/gim2017146">https://www.nature.com/articles/gim2017146</ext-link>)</td></tr><tr><td> Uses polymerase chain reaction to detect CGG repeats in the <italic>FMR1</italic> gene</td></tr><tr><td> &#x0003e;200 repeats cause Fragile X Syndrome, while 55&#x02013;200 repeats is associated with Fragile X premutation-associated conditions (<ext-link ext-link-type="uri" xlink:href="https://www.futuremedicine.com/doi/full/10.2217/fnl.14.11">https://www.futuremedicine.com/doi/full/10.2217/fnl.14.11</ext-link>)</td></tr><tr><td><bold>Chromosomal microarray</bold></td></tr><tr><td> Detects genomic deletions and duplications as seen in 22q11.2 deletion syndrome or 15q11.2 duplication</td></tr><tr><td> Considered a first-tier test for NDDs with diagnostic yield of 10&#x02013;20% (<ext-link ext-link-type="uri" xlink:href="https://www.sciencedirect.com/science/article/pii/S0002929710002089">https://www.sciencedirect.com/science/article/pii/S0002929710002089</ext-link>)</td></tr><tr><td><bold>Gene panel testing</bold></td></tr><tr><td> Varies widely depending on the specific company</td></tr><tr><td> Detects a limited range of genetic variants known to be associated with NDDs</td></tr><tr><td><bold>Whole exome sequencing</bold></td></tr><tr><td> Uses next-generation sequencing to identify single base pair changes (single nucleotide variants) in gene-coding regions (exons)</td></tr><tr><td> Recent recommendations to include as first- or second-tier test for NDDs with diagnostic yields up to ~50% in most severely affected patients<sup><xref ref-type="bibr" rid="CR80">80</xref></sup>.</td></tr><tr><td> Does not detect genomic deletions/duplications or repeat expansions</td></tr><tr><td><bold>Whole genome sequencing</bold></td></tr><tr><td> Uses next-generation sequencing to identify single base pair changes (single nucleotide variants) in both gene-coding regions (exons) and gene regulatory regions (introns)</td></tr><tr><td> Can detect genomic deletions/duplications, but not repeat expansions</td></tr><tr><td> Recent recommendations to include as first- or second-tier test for NDDs with diagnostic yields up to ~50% in most severely affected patients<sup><xref ref-type="bibr" rid="CR80">80</xref></sup>.</td></tr><tr><td><bold>DNA methylation analysis</bold></td></tr><tr><td> For a few NDDs such as Beckwith-Wiedemann, Prader-Willi, and Angelman syndromes, abnormal methylation patterns are causative (<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/28818477/">https://pubmed.ncbi.nlm.nih.gov/28818477/</ext-link>)</td></tr><tr><td> Usually only ordered when clinically suspected</td></tr></tbody></table></table-wrap></p><p id="Par18">AIEs such as NMDAR encephalitis, should be considered in any patient with NDDs presenting with catatonia. A standard clinical assessment looking for key features of AIEs including autonomic dysfunction, new-onset seizures, and new focal neurologic disorders, should always be performed<sup><xref ref-type="bibr" rid="CR69">69</xref></sup>. However, these symptoms can sometimes be challenging to differentiate from exacerbations of pre-existing behaviors or neurologic conditions in patients with NDDs. For example, repetitive behaviors can intensify in severity that may be interpreted as hyperactive catatonia and some epilepsy syndromes can present in adolescence<sup><xref ref-type="bibr" rid="CR86">86</xref></sup>, which could be mistaken for a symptom of AIE. When the rate of onset of these symptoms is rapid or subacute, an AIE should be strongly considered and a neuroimmunologic workup, including serum and cerebral spinal fluid studies for anti-neuronal autoantibodies, should be initiated<sup><xref ref-type="bibr" rid="CR87">87</xref>&#x02013;<xref ref-type="bibr" rid="CR89">89</xref></sup>. If there is strong suspicion for an AIE in a patient with catatonia, immunomodulatory treatments, like intravenous immunoglobulins or systemic glucocorticoids<sup><xref ref-type="bibr" rid="CR87">87</xref>&#x02013;<xref ref-type="bibr" rid="CR89">89</xref></sup> may be considered prior to benzodiazepine or ECT treatment in order to target the underlying cause (Fig. <xref rid="Fig2" ref-type="fig">2</xref>). Caution should be taken in basing the diagnosis of catatonia off of treatment response alone, as individuals with catatonia due to an underlying AIE may respond to benzodiazepines or ECT treatment, but this may preclude the initiation of definitive immunomodulatory management and could result in poor long-term outcomes<sup><xref ref-type="bibr" rid="CR66">66</xref></sup>. Furthermore, the diagnosis of AIE should trigger an evaluation for malignancy, as these conditions can occur as part of a paraneoplastic syndrome<sup><xref ref-type="bibr" rid="CR90">90</xref></sup>.</p><p id="Par19">Immunomodulatory therapies are also being actively explored in the treatment of ASD. Minocycline and Vitamin D have been shown to modulate microglial activation and improve ASD-related behaviors in animal models<sup><xref ref-type="bibr" rid="CR91">91</xref>,<xref ref-type="bibr" rid="CR92">92</xref></sup>. Given the possibility of some convergent neuroimmune mechanisms involving microglia, the question arises of whether patients with co-occurring NDD and catatonia may benefit more than neurotypical peers from immunomodulatory treatment. Four patients were recently described with <italic>SHANK3</italic>-associated NDDs (including but not limited to ASD) and comorbid neuropsychiatric symptoms, including catatonia<sup><xref ref-type="bibr" rid="CR82">82</xref></sup>. They were treatment-resistant to standard psychotropics, but were rapidly responsive to immunomodulatory treatments, such as intravenous immunoglobulins, mycophenolate, and rituximab<sup><xref ref-type="bibr" rid="CR82">82</xref></sup>. Larger, randomized trials are needed to clarify the role of these medications in treating patients with NDDs and catatonia, but there is growing evidence that they may especially benefit from expedient neuroimmunologic evaluation and treatment.</p></sec><sec id="Sec10"><title>Treatment</title><p id="Par20">There is a dearth of research on the behavioral interventions for catatonia in patients with NDDs. Behavioral interventions targeting sensory, perceptual, and neurocognitive functioning have been attempted with mixed results<sup><xref ref-type="bibr" rid="CR10">10</xref></sup>, but with some recent success using a &#x0201c;prompt-fading&#x0201d; approach, where behavioral interventions are slowly reduced overtime until the patient is able to function more independently<sup><xref ref-type="bibr" rid="CR93">93</xref>,<xref ref-type="bibr" rid="CR94">94</xref></sup>. Reducing stressors, providing structure throughout the day with activities that bring the patient joy, and using prompts to overcome movement difficulties improved clinician-reported ratings of movement, response, and functional independence<sup><xref ref-type="bibr" rid="CR3">3</xref>,<xref ref-type="bibr" rid="CR95">95</xref></sup>. These studies suggest that behavioral therapies may have a role in improving symptoms of mild catatonia in patients with NDDs or augmenting other treatments, but there is currently insufficient data to recommend behavioral interventions as a primary treatment approach.</p><p id="Par21">The use of medications for the treatment of catatonia in neurotypical patients and patients with NDDs and catatonia follows a similar path. The gold standard pharmacotherapy continues to be benzodiazepines, such as lorazepam in doses ranging from 6&#x02013;24&#x02009;mg<sup><xref ref-type="bibr" rid="CR96">96</xref>,<xref ref-type="bibr" rid="CR97">97</xref></sup>. Second- and third-line agents, such as zolpidem or amantadine, for neurotypical adults currently have no safety or efficacy data in patients with NDDs and catatonia. There are preliminary reports of genetically guided treatment for catatonia, where patients with <italic>SHANK3</italic> variants and catatonia responding positively to lithium therapy<sup><xref ref-type="bibr" rid="CR81">81</xref>,<xref ref-type="bibr" rid="CR98">98</xref></sup> and to immunomodulation<sup><xref ref-type="bibr" rid="CR82">82</xref></sup>.</p><p id="Par22">For patients with catatonia that see little or no benefit from treatment with benzodiazepines, ECT remains the gold standard<sup><xref ref-type="bibr" rid="CR99">99</xref></sup>. An especially high ethical bar must be met for providing ECT to patients with NDDs and catatonia, as they often cannot provide informed consent either due to their baseline intellectual disability, their acute psychiatric state, or both, and are thus highly vulnerable<sup><xref ref-type="bibr" rid="CR100">100</xref></sup>. ECT might be considered earlier in the treatment algorithm if the situation is emergent, such as in the case of malignant catatonia (Fig. <xref rid="Fig2" ref-type="fig">2</xref>). While it is not definitively established if severe SIBs are nosologically separate from catatonia, ECT can be an effective treatment for both conditions. For example, a patient with an NDD who had 100 self-injurious episodes per hour was diagnosed with hyperactive catatonia and treated with ECT 3&#x000d7;/week for 5 weeks, resulting in a decreased number of episodes to 20 per hour<sup><xref ref-type="bibr" rid="CR101">101</xref></sup>.</p></sec></sec><sec id="Sec11" sec-type="discussion"><title>Discussion</title><p id="Par23">We share our perspective on some of the most important recent advances in the understanding of catatonia in patients with NDDs and highlight some of the biggest gaps in our knowledge in this state-of-the-art (non-systematic) review. While we made every effort to be comprehensive, inclusive, and unbiased in our literature search and analysis, some work invariably was given more weight than others, which is a limitation. We synthesize the current literature and propose a novel evaluation and treatment algorithm (Fig. <xref rid="Fig2" ref-type="fig">2</xref>) that has some similarities to previous recommendations<sup><xref ref-type="bibr" rid="CR12">12</xref></sup>, but with important advancements (highlighted in blue) leveraging the most recent developments in our understanding of the behavioral, genetic, and autoimmune bases of NDDs and catatonia. We envision a future in which patients with NDDs impacted by catatonia may undergo a rapid molecular evaluation that has the potential to yield both diagnostic information and inform precision treatment plans. Due to the significant morbidity associated with severe forms of catatonia, patients stand to benefit from the rapidly improving turnaround time for genomic and serological analyses<sup><xref ref-type="bibr" rid="CR102">102</xref></sup>.</p><p id="Par24">A significant future challenge will be figuring out how to further refine and validate the diagnosis of catatonia for patients with NDDs, given the heterogenous presentations along with symptom overlap. The use of standardized scales in assessment and case reporting could help improve comparability of cases and aid our understanding of the progression of catatonia in the NDD population. Rigorous, prospective, multi-institutional studies will be necessary to recruit sufficiently large cohorts of patients to address these questions. As has been demonstrated for NDDs in general, a robust understanding of genetic risk factors for catatonia in NDDs could shed light on the neurobiological underpinnings<sup><xref ref-type="bibr" rid="CR103">103</xref></sup>. Epigenetic studies may shed light on how psychological distress and trauma can shift neurocircuitry towards a state of catatonia in individuals with NDDs<sup><xref ref-type="bibr" rid="CR104">104</xref></sup>. The use of animal or organoid models of genetic syndromes known to predispose to catatonia, such as 22q13.3 deletion syndrome or Prader&#x02013;Willi Syndromes, may be particularly illuminating, as they may provide insights that generalize to idiopathic cases of NDDs<sup><xref ref-type="bibr" rid="CR105">105</xref></sup>.</p></sec></body><back><fn-group><fn><p><bold>Publisher&#x02019;s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>These authors contributed equally: Shavon Moore, Debha N. Amatya.</p></fn></fn-group><ack><title>Acknowledgements</title><p>Thee authors would like to thank the UCSD Department of Psychiatry, Rady Children&#x02019;s Hospital San Diego Division of Behavioral Health Services, and the Rady Children&#x02019;s Institute for Genomic Medicine for their support.</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>S.M. - literature search, writing, tables, manuscript review, and editing. D.N.A. - literature search, writing, tables, manuscript review, and editing. M.M.C. - literature search, writing, tables, figures, manuscript review, and editing. A.D.B. - project conception, literature search, writing, tables, figures, manuscript review, and editing.</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>All data from this publication is freely available upon request</p></notes><notes notes-type="data-availability"><title>Code availability</title><p>There is no code associated with this publication.</p></notes><notes id="FPar1" notes-type="COI-statement"><title>Competing interests</title><p id="Par25">The authors declare no competing interests.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><mixed-citation publication-type="other">American Psychiatric Association. Desk reference to the diagnostic criteria from DSM-5&#x02122;. American Psychiatric Publishing, Inc., 60&#x02013;62 (2013).</mixed-citation></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name><surname>Consoli</surname><given-names>A</given-names></name><etal/></person-group><article-title>Electroconvulsive therapy in adolescents with intellectual disability and severe self-injurious behavior and aggression: A retrospective study</article-title><source>Eur. Child Adolesc. Psychiatry</source><year>2013</year><volume>22</volume><fpage>55</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1007/s00787-012-0320-7</pub-id><pub-id pub-id-type="pmid">22923049</pub-id>
</element-citation><mixed-citation id="mc-CR2" publication-type="journal">Consoli, A. et al. Electroconvulsive therapy in adolescents with intellectual disability and severe self-injurious behavior and aggression: A retrospective study. <italic>Eur. Child Adolesc. Psychiatry</italic><bold>22</bold>, 55&#x02013;62 (2013).<pub-id pub-id-type="pmid">22923049</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name><surname>Wing</surname><given-names>L</given-names></name><name><surname>Shah</surname><given-names>A</given-names></name></person-group><article-title>Catatonia in autistic spectrum disorders</article-title><source>Br. J. Psychiatry</source><year>2000</year><volume>176</volume><fpage>357</fpage><lpage>362</lpage><pub-id pub-id-type="doi">10.1192/bjp.176.4.357</pub-id><pub-id pub-id-type="pmid">10827884</pub-id>
</element-citation><mixed-citation id="mc-CR3" publication-type="journal">Wing, L. &#x00026; Shah, A. Catatonia in autistic spectrum disorders. <italic>Br. J. Psychiatry</italic><bold>176</bold>, 357&#x02013;362 (2000).<pub-id pub-id-type="pmid">10827884</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name><surname>Gillberg</surname><given-names>C</given-names></name><name><surname>Steffenburg</surname><given-names>S</given-names></name></person-group><article-title>Outcome and prognostic factors in infantile autism and similar conditions: A population-based study of 46 cases followed through puberty</article-title><source>J. Autism Dev. Disord.</source><year>1987</year><volume>17</volume><fpage>273</fpage><lpage>287</lpage><pub-id pub-id-type="doi">10.1007/BF01495061</pub-id><pub-id pub-id-type="pmid">3610999</pub-id>
</element-citation><mixed-citation id="mc-CR4" publication-type="journal">Gillberg, C. &#x00026; Steffenburg, S. Outcome and prognostic factors in infantile autism and similar conditions: A population-based study of 46 cases followed through puberty. <italic>J. Autism Dev. Disord.</italic><bold>17</bold>, 273&#x02013;287 (1987).<pub-id pub-id-type="pmid">3610999</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name><surname>Ghaziuddin</surname><given-names>N</given-names></name><name><surname>Dhossche</surname><given-names>D</given-names></name><name><surname>Marcotte</surname><given-names>K</given-names></name></person-group><article-title>Retrospective chart review of catatonia in child and adolescent psychiatric patients</article-title><source>Acta Psychiatr. Scand.</source><year>2012</year><volume>125</volume><fpage>33</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1111/j.1600-0447.2011.01778.x</pub-id><pub-id pub-id-type="pmid">22040029</pub-id>
</element-citation><mixed-citation id="mc-CR5" publication-type="journal">Ghaziuddin, N., Dhossche, D. &#x00026; Marcotte, K. Retrospective chart review of catatonia in child and adolescent psychiatric patients. <italic>Acta Psychiatr. Scand.</italic><bold>125</bold>, 33&#x02013;38 (2012).<pub-id pub-id-type="pmid">22040029</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name><surname>Billstedt</surname><given-names>E</given-names></name><name><surname>Gillberg</surname><given-names>C</given-names></name><name><surname>Gillberg</surname><given-names>C</given-names></name></person-group><article-title>Autism after adolescence: Population-based 13- to 22-year follow-up study of 120 individuals with autism diagnosed in childhood</article-title><source>J. Autism Dev. Disord.</source><year>2005</year><volume>35</volume><fpage>351</fpage><lpage>360</lpage><pub-id pub-id-type="doi">10.1007/s10803-005-3302-5</pub-id><pub-id pub-id-type="pmid">16119476</pub-id>
</element-citation><mixed-citation id="mc-CR6" publication-type="journal">Billstedt, E., Gillberg, C. &#x00026; Gillberg, C. Autism after adolescence: Population-based 13- to 22-year follow-up study of 120 individuals with autism diagnosed in childhood. <italic>J. Autism Dev. Disord.</italic><bold>35</bold>, 351&#x02013;360 (2005).<pub-id pub-id-type="pmid">16119476</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name><surname>Solmi</surname><given-names>M</given-names></name><etal/></person-group><article-title>Prevalence of catatonia and its moderators in clinical samples: Results from a meta-analysis and meta-regression analysis</article-title><source>Schizophr. Bull.</source><year>2018</year><volume>44</volume><fpage>1133</fpage><lpage>1150</lpage><pub-id pub-id-type="doi">10.1093/schbul/sbx157</pub-id><pub-id pub-id-type="pmid">29140521</pub-id>
</element-citation><mixed-citation id="mc-CR7" publication-type="journal">Solmi, M. et al. Prevalence of catatonia and its moderators in clinical samples: Results from a meta-analysis and meta-regression analysis. <italic>Schizophr. Bull.</italic><bold>44</bold>, 1133&#x02013;1150 (2018).<pub-id pub-id-type="pmid">29140521</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name><surname>Dhossche</surname><given-names>DM</given-names></name><name><surname>Wilson</surname><given-names>C</given-names></name><name><surname>Wachtel</surname><given-names>LE</given-names></name></person-group><article-title>Catatonia in childhood and adolescence: Implications for the DSM-5</article-title><source>Prim. Psychiatry</source><year>2010</year><volume>17</volume><fpage>35</fpage><lpage>39</lpage></element-citation><mixed-citation id="mc-CR8" publication-type="journal">Dhossche, D. M., Wilson, C. &#x00026; Wachtel, L. E. Catatonia in childhood and adolescence: Implications for the DSM-5. <italic>Prim. Psychiatry</italic><bold>17</bold>, 35&#x02013;39 (2010).</mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name><surname>Wachtel</surname><given-names>LE</given-names></name></person-group><article-title>The multiple faces of catatonia in autism spectrum disorders: Descriptive clinical experience of 22 patients over 12 years</article-title><source>Eur. Child Adolesc. Psychiatry</source><year>2019</year><volume>28</volume><fpage>471</fpage><lpage>480</lpage><pub-id pub-id-type="doi">10.1007/s00787-018-1210-4</pub-id><pub-id pub-id-type="pmid">30069655</pub-id>
</element-citation><mixed-citation id="mc-CR9" publication-type="journal">Wachtel, L. E. The multiple faces of catatonia in autism spectrum disorders: Descriptive clinical experience of 22 patients over 12 years. <italic>Eur. Child Adolesc. Psychiatry</italic><bold>28</bold>, 471&#x02013;480 (2019).<pub-id pub-id-type="pmid">30069655</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name><surname>DeJong</surname><given-names>H</given-names></name><name><surname>Bunton</surname><given-names>P</given-names></name><name><surname>Hare</surname><given-names>DJ</given-names></name></person-group><article-title>A systematic review of interventions used to treat catatonic symptoms in people with autistic spectrum disorders</article-title><source>J. Autism Dev. Disord.</source><year>2014</year><volume>44</volume><fpage>2127</fpage><lpage>2136</lpage><pub-id pub-id-type="doi">10.1007/s10803-014-2085-y</pub-id><pub-id pub-id-type="pmid">24643578</pub-id>
</element-citation><mixed-citation id="mc-CR10" publication-type="journal">DeJong, H., Bunton, P. &#x00026; Hare, D. J. A systematic review of interventions used to treat catatonic symptoms in people with autistic spectrum disorders. <italic>J. Autism Dev. Disord.</italic><bold>44</bold>, 2127&#x02013;2136 (2014).<pub-id pub-id-type="pmid">24643578</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name><surname>Benarous</surname><given-names>X</given-names></name><name><surname>Raffin</surname><given-names>M</given-names></name><name><surname>Ferrafiat</surname><given-names>V</given-names></name><name><surname>Consoli</surname><given-names>A</given-names></name><name><surname>Cohen</surname><given-names>D</given-names></name></person-group><article-title>Catatonia in children and adolescents: New perspectives</article-title><source>Schizophr. Res.</source><year>2018</year><volume>200</volume><fpage>56</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1016/j.schres.2017.07.028</pub-id><pub-id pub-id-type="pmid">28754582</pub-id>
</element-citation><mixed-citation id="mc-CR11" publication-type="journal">Benarous, X., Raffin, M., Ferrafiat, V., Consoli, A. &#x00026; Cohen, D. Catatonia in children and adolescents: New perspectives. <italic>Schizophr. Res.</italic><bold>200</bold>, 56&#x02013;67 (2018).<pub-id pub-id-type="pmid">28754582</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name><surname>Mazzone</surname><given-names>L</given-names></name><name><surname>Postorino</surname><given-names>V</given-names></name><name><surname>Valeri</surname><given-names>G</given-names></name><name><surname>Vicari</surname><given-names>S</given-names></name></person-group><article-title>Catatonia in patients with autism: Prevalence and management</article-title><source>CNS Drugs</source><year>2014</year><volume>28</volume><fpage>205</fpage><lpage>215</lpage><pub-id pub-id-type="doi">10.1007/s40263-014-0143-9</pub-id><pub-id pub-id-type="pmid">24504828</pub-id>
</element-citation><mixed-citation id="mc-CR12" publication-type="journal">Mazzone, L., Postorino, V., Valeri, G. &#x00026; Vicari, S. Catatonia in patients with autism: Prevalence and management. <italic>CNS Drugs</italic><bold>28</bold>, 205&#x02013;215 (2014).<pub-id pub-id-type="pmid">24504828</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name><surname>Realmuto</surname><given-names>GM</given-names></name><name><surname>August</surname><given-names>GJ</given-names></name></person-group><article-title>Catatonia in autistic disorder: A sign of comorbidity or variable expression?</article-title><source>J. Autism Dev. Disord.</source><year>1991</year><volume>21</volume><fpage>517</fpage><lpage>528</lpage><pub-id pub-id-type="doi">10.1007/BF02206874</pub-id><pub-id pub-id-type="pmid">1778964</pub-id>
</element-citation><mixed-citation id="mc-CR13" publication-type="journal">Realmuto, G. M. &#x00026; August, G. J. Catatonia in autistic disorder: A sign of comorbidity or variable expression? <italic>J. Autism Dev. Disord.</italic><bold>21</bold>, 517&#x02013;528 (1991).<pub-id pub-id-type="pmid">1778964</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name><surname>Wachtel</surname><given-names>LE</given-names></name><name><surname>Dhossche</surname><given-names>DM</given-names></name></person-group><article-title>Self-injury in autism as an alternate sign of catatonia: Implications for electroconvulsive therapy</article-title><source>Med. Hypotheses</source><year>2010</year><volume>75</volume><fpage>111</fpage><lpage>114</lpage><pub-id pub-id-type="doi">10.1016/j.mehy.2010.02.001</pub-id><pub-id pub-id-type="pmid">20202760</pub-id>
</element-citation><mixed-citation id="mc-CR14" publication-type="journal">Wachtel, L. E. &#x00026; Dhossche, D. M. Self-injury in autism as an alternate sign of catatonia: Implications for electroconvulsive therapy. <italic>Med. Hypotheses</italic><bold>75</bold>, 111&#x02013;114 (2010).<pub-id pub-id-type="pmid">20202760</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name><surname>Ghaziuddin</surname><given-names>M</given-names></name><name><surname>Quinlan</surname><given-names>P</given-names></name><name><surname>Ghaziuddin</surname><given-names>N</given-names></name></person-group><article-title>Catatonia in autism: A distinct subtype?</article-title><source>J. Intellect. Disabil. Res.</source><year>2005</year><volume>49</volume><fpage>102</fpage><lpage>105</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2788.2005.00666.x</pub-id><pub-id pub-id-type="pmid">15634317</pub-id>
</element-citation><mixed-citation id="mc-CR15" publication-type="journal">Ghaziuddin, M., Quinlan, P. &#x00026; Ghaziuddin, N. Catatonia in autism: A distinct subtype? <italic>J. Intellect. Disabil. Res.</italic><bold>49</bold>, 102&#x02013;105 (2005).<pub-id pub-id-type="pmid">15634317</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name><surname>Bozkurt</surname><given-names>H</given-names></name><name><surname>Mukaddes</surname><given-names>NM</given-names></name></person-group><article-title>Catatonia in a child with autistic disorder</article-title><source>Turk. J. Pediatr.</source><year>2010</year><volume>52</volume><fpage>435</fpage><lpage>438</lpage><pub-id pub-id-type="pmid">21043395</pub-id>
</element-citation><mixed-citation id="mc-CR16" publication-type="journal">Bozkurt, H. &#x00026; Mukaddes, N. M. Catatonia in a child with autistic disorder. <italic>Turk. J. Pediatr.</italic><bold>52</bold>, 435&#x02013;438 (2010).<pub-id pub-id-type="pmid">21043395</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><mixed-citation publication-type="other">Dhossche, D. M. Catatonia: The ultimate yet treatable motor reaction to fear in autism. <italic>Autism - Open Access</italic><bold>01</bold>, 1 (2012).</mixed-citation></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name><surname>Shorter</surname><given-names>E</given-names></name><name><surname>Wachtel</surname><given-names>LE</given-names></name></person-group><article-title>Childhood catatonia, autism and psychosis past and present: Is there an &#x02018;iron triangle&#x02019;?</article-title><source>Acta Psychiatr. Scand.</source><year>2013</year><volume>128</volume><fpage>21</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1111/acps.12082</pub-id><pub-id pub-id-type="pmid">23350770</pub-id>
</element-citation><mixed-citation id="mc-CR18" publication-type="journal">Shorter, E. &#x00026; Wachtel, L. E. Childhood catatonia, autism and psychosis past and present: Is there an &#x02018;iron triangle&#x02019;? <italic>Acta Psychiatr. Scand.</italic><bold>128</bold>, 21&#x02013;33 (2013).<pub-id pub-id-type="pmid">23350770</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name><surname>Rutter</surname><given-names>M</given-names></name></person-group><article-title>Childhood schizophrenia reconsidered</article-title><source>J. Autism Child. Schizophr.</source><year>1972</year><volume>2</volume><fpage>315</fpage><lpage>337</lpage><pub-id pub-id-type="doi">10.1007/BF01537622</pub-id><pub-id pub-id-type="pmid">4581613</pub-id>
</element-citation><mixed-citation id="mc-CR19" publication-type="journal">Rutter, M. Childhood schizophrenia reconsidered. <italic>J. Autism Child. Schizophr.</italic><bold>2</bold>, 315&#x02013;337 (1972).<pub-id pub-id-type="pmid">4581613</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name><surname>Dhossche</surname><given-names>DM</given-names></name><name><surname>Reti</surname><given-names>IM</given-names></name><name><surname>Wachtel</surname><given-names>LE</given-names></name></person-group><article-title>Catatonia and autism: A historical review, with implications for electroconvulsive therapy</article-title><source>J. ECT</source><year>2009</year><volume>25</volume><fpage>19</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1097/YCT.0b013e3181957363</pub-id><pub-id pub-id-type="pmid">19190507</pub-id>
</element-citation><mixed-citation id="mc-CR20" publication-type="journal">Dhossche, D. M., Reti, I. M. &#x00026; Wachtel, L. E. Catatonia and autism: A historical review, with implications for electroconvulsive therapy. <italic>J. ECT</italic><bold>25</bold>, 19&#x02013;22 (2009).<pub-id pub-id-type="pmid">19190507</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name><surname>Dhossche</surname><given-names>DM</given-names></name><name><surname>Wachtel</surname><given-names>LE</given-names></name></person-group><article-title>Catatonia is hidden in plain sight among different pediatric disorders: A review article</article-title><source>Pediatr. Neurol.</source><year>2010</year><volume>43</volume><fpage>307</fpage><lpage>315</lpage><pub-id pub-id-type="doi">10.1016/j.pediatrneurol.2010.07.001</pub-id><pub-id pub-id-type="pmid">20933172</pub-id>
</element-citation><mixed-citation id="mc-CR21" publication-type="journal">Dhossche, D. M. &#x00026; Wachtel, L. E. Catatonia is hidden in plain sight among different pediatric disorders: A review article. <italic>Pediatr. Neurol.</italic><bold>43</bold>, 307&#x02013;315 (2010).<pub-id pub-id-type="pmid">20933172</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name><surname>Hare</surname><given-names>DJ</given-names></name><name><surname>Malone</surname><given-names>C</given-names></name></person-group><article-title>Catatonia and autistic spectrum disorders</article-title><source>Autism</source><year>2004</year><volume>8</volume><fpage>183</fpage><lpage>195</lpage><pub-id pub-id-type="doi">10.1177/1362361304042722</pub-id><pub-id pub-id-type="pmid">15165434</pub-id>
</element-citation><mixed-citation id="mc-CR22" publication-type="journal">Hare, D. J. &#x00026; Malone, C. Catatonia and autistic spectrum disorders. <italic>Autism</italic><bold>8</bold>, 183&#x02013;195 (2004).<pub-id pub-id-type="pmid">15165434</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name><surname>Cavanna</surname><given-names>AE</given-names></name><name><surname>Robertson</surname><given-names>MM</given-names></name><name><surname>Critchley</surname><given-names>HD</given-names></name></person-group><article-title>Catatonic signs in Gilles de la Tourette syndrome</article-title><source>Cogn. Behav. Neurol.</source><year>2008</year><volume>21</volume><fpage>34</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1097/WNN.0b013e318165a9cf</pub-id><pub-id pub-id-type="pmid">18327021</pub-id>
</element-citation><mixed-citation id="mc-CR23" publication-type="journal">Cavanna, A. E., Robertson, M. M. &#x00026; Critchley, H. D. Catatonic signs in Gilles de la Tourette syndrome. <italic>Cogn. Behav. Neurol.</italic><bold>21</bold>, 34&#x02013;37 (2008).<pub-id pub-id-type="pmid">18327021</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name><surname>Nickerson</surname><given-names>RS</given-names></name></person-group><article-title>Confirmation bias: A ubiquitous phenomenon in many guises</article-title><source>Rev. Gen. Psychol.</source><year>1998</year><volume>2</volume><fpage>175</fpage><lpage>220</lpage><pub-id pub-id-type="doi">10.1037/1089-2680.2.2.175</pub-id></element-citation><mixed-citation id="mc-CR24" publication-type="journal">Nickerson, R. S. Confirmation bias: A ubiquitous phenomenon in many guises. <italic>Rev. Gen. Psychol.</italic><bold>2</bold>, 175&#x02013;220 (1998).</mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name><surname>Dwan</surname><given-names>K</given-names></name><etal/></person-group><article-title>Systematic review of the empirical evidence of study publication bias and outcome reporting bias</article-title><source>PLoS One</source><year>2008</year><volume>3</volume><fpage>e3081</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0003081</pub-id><pub-id pub-id-type="pmid">18769481</pub-id>
</element-citation><mixed-citation id="mc-CR25" publication-type="journal">Dwan, K. et al. Systematic review of the empirical evidence of study publication bias and outcome reporting bias. <italic>PLoS One</italic><bold>3</bold>, e3081 (2008).<pub-id pub-id-type="pmid">18769481</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name><surname>Dhossche</surname><given-names>DM</given-names></name><name><surname>Ross</surname><given-names>CA</given-names></name><name><surname>Stoppelbein</surname><given-names>L</given-names></name></person-group><article-title>The role of deprivation, abuse, and trauma in pediatric catatonia without a clear medical cause</article-title><source>Acta Psychiatr. Scand.</source><year>2012</year><volume>125</volume><fpage>25</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1111/j.1600-0447.2011.01779.x</pub-id><pub-id pub-id-type="pmid">22017207</pub-id>
</element-citation><mixed-citation id="mc-CR26" publication-type="journal">Dhossche, D. M., Ross, C. A. &#x00026; Stoppelbein, L. The role of deprivation, abuse, and trauma in pediatric catatonia without a clear medical cause. <italic>Acta Psychiatr. Scand.</italic><bold>125</bold>, 25&#x02013;32 (2012).<pub-id pub-id-type="pmid">22017207</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name><surname>Moskowitz</surname><given-names>AK</given-names></name></person-group><article-title>Scared stiff&#x02019;: Catatonia as an evolutionary-based fear response</article-title><source>Psychol. Rev.</source><year>2004</year><volume>111</volume><fpage>984</fpage><pub-id pub-id-type="doi">10.1037/0033-295X.111.4.984</pub-id><pub-id pub-id-type="pmid">15482070</pub-id>
</element-citation><mixed-citation id="mc-CR27" publication-type="journal">Moskowitz, A. K. Scared stiff&#x02019;: Catatonia as an evolutionary-based fear response. <italic>Psychol. Rev.</italic><bold>111</bold>, 984 (2004).<pub-id pub-id-type="pmid">15482070</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name><surname>Lask</surname><given-names>B</given-names></name></person-group><article-title>Pervasive refusal syndrome</article-title><source>Adv. Psychiatr. Treat.</source><year>2004</year><volume>10</volume><fpage>153</fpage><lpage>159</lpage><pub-id pub-id-type="doi">10.1192/apt.10.2.153</pub-id></element-citation><mixed-citation id="mc-CR28" publication-type="journal">Lask, B. Pervasive refusal syndrome. <italic>Adv. Psychiatr. Treat.</italic><bold>10</bold>, 153&#x02013;159 (2004).</mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name><surname>Dhossche</surname><given-names>D</given-names></name><name><surname>Kellner</surname><given-names>CH</given-names></name></person-group><article-title>Pervasive refusal syndrome: A misnomer for catatonia</article-title><source>Asian J. Psychiatr.</source><year>2015</year><volume>18</volume><fpage>113</fpage><pub-id pub-id-type="doi">10.1016/j.ajp.2015.09.002</pub-id><pub-id pub-id-type="pmid">26427582</pub-id>
</element-citation><mixed-citation id="mc-CR29" publication-type="journal">Dhossche, D. &#x00026; Kellner, C. H. Pervasive refusal syndrome: A misnomer for catatonia. <italic>Asian J. Psychiatr.</italic><bold>18</bold>, 113 (2015).<pub-id pub-id-type="pmid">26427582</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name><surname>Kirkhart</surname><given-names>R</given-names></name><etal/></person-group><article-title>The detection and measurement of catatonia</article-title><source>Psychiatry</source><year>2007</year><volume>4</volume><fpage>52</fpage><pub-id pub-id-type="pmid">20532121</pub-id>
</element-citation><mixed-citation id="mc-CR30" publication-type="journal">Kirkhart, R. et al. The detection and measurement of catatonia. <italic>Psychiatry</italic><bold>4</bold>, 52 (2007).<pub-id pub-id-type="pmid">20532121</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name><surname>Carroll</surname><given-names>BT</given-names></name><etal/></person-group><article-title>Katatonia: A new conceptual understanding of catatonia and a new rating scale</article-title><source>Psychiatry</source><year>2008</year><volume>5</volume><fpage>42</fpage><pub-id pub-id-type="pmid">19724775</pub-id>
</element-citation><mixed-citation id="mc-CR31" publication-type="journal">Carroll, B. T. et al. Katatonia: A new conceptual understanding of catatonia and a new rating scale. <italic>Psychiatry</italic><bold>5</bold>, 42 (2008).<pub-id pub-id-type="pmid">19724775</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name><surname>Benarous</surname><given-names>X</given-names></name><etal/></person-group><article-title>Validation of the Pediatric Catatonia Rating Scale (PCRS)</article-title><source>Schizophr. Res.</source><year>2016</year><volume>176</volume><fpage>378</fpage><lpage>386</lpage><pub-id pub-id-type="doi">10.1016/j.schres.2016.06.020</pub-id><pub-id pub-id-type="pmid">27377978</pub-id>
</element-citation><mixed-citation id="mc-CR32" publication-type="journal">Benarous, X. et al. Validation of the Pediatric Catatonia Rating Scale (PCRS). <italic>Schizophr. Res.</italic><bold>176</bold>, 378&#x02013;386 (2016).<pub-id pub-id-type="pmid">27377978</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name><surname>Breen</surname><given-names>J</given-names></name><name><surname>Hare</surname><given-names>DJ</given-names></name></person-group><article-title>The nature and prevalence of catatonic symptoms in young people with autism</article-title><source>J. Intellect. Disabil. Res.</source><year>2017</year><volume>61</volume><fpage>580</fpage><lpage>593</lpage><pub-id pub-id-type="doi">10.1111/jir.12362</pub-id><pub-id pub-id-type="pmid">28150394</pub-id>
</element-citation><mixed-citation id="mc-CR33" publication-type="journal">Breen, J. &#x00026; Hare, D. J. The nature and prevalence of catatonic symptoms in young people with autism. <italic>J. Intellect. Disabil. Res.</italic><bold>61</bold>, 580&#x02013;593 (2017).<pub-id pub-id-type="pmid">28150394</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name><surname>Walther</surname><given-names>S</given-names></name><name><surname>Stegmayer</surname><given-names>K</given-names></name><name><surname>Wilson</surname><given-names>JE</given-names></name><name><surname>Heckers</surname><given-names>S</given-names></name></person-group><article-title>Structure and neural mechanisms of catatonia</article-title><source>Lancet Psychiatry</source><year>2019</year><volume>6</volume><fpage>610</fpage><lpage>619</lpage><pub-id pub-id-type="doi">10.1016/S2215-0366(18)30474-7</pub-id><pub-id pub-id-type="pmid">31196794</pub-id>
</element-citation><mixed-citation id="mc-CR34" publication-type="journal">Walther, S., Stegmayer, K., Wilson, J. E. &#x00026; Heckers, S. Structure and neural mechanisms of catatonia. <italic>Lancet Psychiatry</italic><bold>6</bold>, 610&#x02013;619 (2019).<pub-id pub-id-type="pmid">31196794</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name><surname>Zimmerman</surname><given-names>R</given-names></name><name><surname>Pal</surname><given-names>DK</given-names></name><name><surname>Tin</surname><given-names>A</given-names></name><name><surname>Ahsan</surname><given-names>H</given-names></name><name><surname>Greenberg</surname><given-names>DA</given-names></name></person-group><article-title>Methods for assessing familial aggregation: Family history measures and confounding in the standard cohort, reconstructed cohort and case-control designs</article-title><source>Hum. Hered.</source><year>2009</year><volume>68</volume><fpage>201</fpage><pub-id pub-id-type="doi">10.1159/000224640</pub-id><pub-id pub-id-type="pmid">19521102</pub-id>
</element-citation><mixed-citation id="mc-CR35" publication-type="journal">Zimmerman, R., Pal, D. K., Tin, A., Ahsan, H. &#x00026; Greenberg, D. A. Methods for assessing familial aggregation: Family history measures and confounding in the standard cohort, reconstructed cohort and case-control designs. <italic>Hum. Hered.</italic><bold>68</bold>, 201 (2009).<pub-id pub-id-type="pmid">19521102</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name><surname>Peralta</surname><given-names>V</given-names></name><name><surname>Fa&#x000f1;an&#x000e1;s</surname><given-names>L</given-names></name><name><surname>Martin-Reyes</surname><given-names>M</given-names></name><name><surname>Cuesta</surname><given-names>MJ</given-names></name></person-group><article-title>Dissecting the catatonia phenotype in psychotic and mood disorders on the basis of familial-genetic factors</article-title><source>Schizophr. Res.</source><year>2018</year><volume>200</volume><fpage>20</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1016/j.schres.2017.09.013</pub-id><pub-id pub-id-type="pmid">28919129</pub-id>
</element-citation><mixed-citation id="mc-CR36" publication-type="journal">Peralta, V., Fa&#x000f1;an&#x000e1;s, L., Martin-Reyes, M. &#x00026; Cuesta, M. J. Dissecting the catatonia phenotype in psychotic and mood disorders on the basis of familial-genetic factors. <italic>Schizophr. Res.</italic><bold>200</bold>, 20&#x02013;25 (2018).<pub-id pub-id-type="pmid">28919129</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name><surname>Janova</surname><given-names>H</given-names></name><etal/></person-group><article-title>Microglia ablation alleviates myelin-associated catatonic signs in mice</article-title><source>J. Clin. Invest.</source><year>2018</year><volume>128</volume><fpage>734</fpage><lpage>745</lpage><pub-id pub-id-type="doi">10.1172/JCI97032</pub-id><pub-id pub-id-type="pmid">29252214</pub-id>
</element-citation><mixed-citation id="mc-CR37" publication-type="journal">Janova, H. et al. Microglia ablation alleviates myelin-associated catatonic signs in mice. <italic>J. Clin. Invest.</italic><bold>128</bold>, 734&#x02013;745 (2018).<pub-id pub-id-type="pmid">29252214</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><mixed-citation publication-type="other">Liu, C. et al. The schizophrenia genetics knowledgebase: A comprehensive update of findings from candidate gene studies. <italic>Transl. Psychiatry</italic><bold>9</bold>, 205 (2019).</mixed-citation></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name><surname>Raffin</surname><given-names>M</given-names></name><etal/></person-group><article-title>Catatonia in children and adolescents: A high rate of genetic conditions</article-title><source>J. Am. Acad. Child Adolesc. Psychiatry</source><year>2018</year><volume>57</volume><fpage>518</fpage><lpage>525.e1</lpage><pub-id pub-id-type="doi">10.1016/j.jaac.2018.03.020</pub-id><pub-id pub-id-type="pmid">29960699</pub-id>
</element-citation><mixed-citation id="mc-CR39" publication-type="journal">Raffin, M. et al. Catatonia in children and adolescents: A high rate of genetic conditions. <italic>J. Am. Acad. Child Adolesc. Psychiatry</italic><bold>57</bold>, 518&#x02013;525.e1 (2018).<pub-id pub-id-type="pmid">29960699</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><mixed-citation publication-type="other">Poser, H. M. &#x00026; Trutia, A. E. Treatment of a Prader-Willi patient with recurrent catatonia. <italic>Case Rep. Psychiatry</italic><bold>2015</bold>, 697428 (2015).</mixed-citation></ref><ref id="CR41"><label>41.</label><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name><surname>Verhoeven</surname><given-names>WMA</given-names></name><name><surname>Egger</surname><given-names>JIM</given-names></name><name><surname>de Leeuw</surname><given-names>N</given-names></name></person-group><article-title>A longitudinal perspective on the pharmacotherapy of 24 adult patients with Phelan McDermid syndrome</article-title><source>Eur. J. Med. Genet.</source><year>2020</year><volume>63</volume><fpage>103751</fpage><pub-id pub-id-type="doi">10.1016/j.ejmg.2019.103751</pub-id><pub-id pub-id-type="pmid">31465867</pub-id>
</element-citation><mixed-citation id="mc-CR41" publication-type="journal">Verhoeven, W. M. A., Egger, J. I. M. &#x00026; de Leeuw, N. A longitudinal perspective on the pharmacotherapy of 24 adult patients with Phelan McDermid syndrome. <italic>Eur. J. Med. Genet.</italic><bold>63</bold>, 103751 (2020).<pub-id pub-id-type="pmid">31465867</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name><surname>Miles</surname><given-names>JH</given-names></name><name><surname>Takahashi</surname><given-names>N</given-names></name><name><surname>Muckerman</surname><given-names>J</given-names></name><name><surname>Nowell</surname><given-names>KP</given-names></name><name><surname>Ithman</surname><given-names>M</given-names></name></person-group><article-title>Catatonia in down syndrome: Systematic approach to diagnosis, treatment and outcome assessment based on a case series of seven patients</article-title><source>Neuropsychiatr. Dis. Treat.</source><year>2019</year><volume>15</volume><fpage>2723</fpage><lpage>2741</lpage><pub-id pub-id-type="doi">10.2147/NDT.S210613</pub-id><pub-id pub-id-type="pmid">31571888</pub-id>
</element-citation><mixed-citation id="mc-CR42" publication-type="journal">Miles, J. H., Takahashi, N., Muckerman, J., Nowell, K. P. &#x00026; Ithman, M. Catatonia in down syndrome: Systematic approach to diagnosis, treatment and outcome assessment based on a case series of seven patients. <italic>Neuropsychiatr. Dis. Treat.</italic><bold>15</bold>, 2723&#x02013;2741 (2019).<pub-id pub-id-type="pmid">31571888</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR43"><label>43.</label><citation-alternatives><element-citation id="ec-CR43" publication-type="journal"><person-group person-group-type="author"><name><surname>Butcher</surname><given-names>NJ</given-names></name><etal/></person-group><article-title>Neuropsychiatric expression and catatonia in 22q11.2 deletion syndrome: An overview and case series</article-title><source>Am. J. Med. Genet. Part A</source><year>2018</year><volume>176</volume><fpage>2146</fpage><lpage>2159</lpage><pub-id pub-id-type="doi">10.1002/ajmg.a.38708</pub-id><pub-id pub-id-type="pmid">29777584</pub-id>
</element-citation><mixed-citation id="mc-CR43" publication-type="journal">Butcher, N. J. et al. Neuropsychiatric expression and catatonia in 22q11.2 deletion syndrome: An overview and case series. <italic>Am. J. Med. Genet. Part A</italic><bold>176</bold>, 2146&#x02013;2159 (2018).<pub-id pub-id-type="pmid">29777584</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR44"><label>44.</label><citation-alternatives><element-citation id="ec-CR44" publication-type="journal"><person-group person-group-type="author"><name><surname>Walterfang</surname><given-names>M</given-names></name><name><surname>Bonnot</surname><given-names>O</given-names></name><name><surname>Mocellin</surname><given-names>R</given-names></name><name><surname>Velakoulis</surname><given-names>D</given-names></name></person-group><article-title>The neuropsychiatry of inborn errors of metabolism</article-title><source>J. Inherit. Metab. Dis.</source><year>2013</year><volume>36</volume><fpage>687</fpage><lpage>702</lpage><pub-id pub-id-type="doi">10.1007/s10545-013-9618-y</pub-id><pub-id pub-id-type="pmid">23700255</pub-id>
</element-citation><mixed-citation id="mc-CR44" publication-type="journal">Walterfang, M., Bonnot, O., Mocellin, R. &#x00026; Velakoulis, D. The neuropsychiatry of inborn errors of metabolism. <italic>J. Inherit. Metab. Dis.</italic><bold>36</bold>, 687&#x02013;702 (2013).<pub-id pub-id-type="pmid">23700255</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR45"><label>45.</label><mixed-citation publication-type="other">Peter-Ross, E. M. Molecular hypotheses to explain the shared pathways and underlying pathobiological causes in catatonia and in catatonic presentations in neuropsychiatric disorders. <italic>Med. Hypotheses</italic><bold>113</bold>, 54&#x02013;64 (2018).</mixed-citation></ref><ref id="CR46"><label>46.</label><citation-alternatives><element-citation id="ec-CR46" publication-type="journal"><person-group person-group-type="author"><name><surname>Bortolin-Cavaill&#x000e9;</surname><given-names>ML</given-names></name><name><surname>Cavaill&#x000e9;</surname><given-names>J</given-names></name></person-group><article-title>The SNORD115 (H/MBII-52) and SNORD116 (H/MBII-85) gene clusters at the imprinted Prader&#x02013;Willi locus generate canonical box C/D snoRNAs</article-title><source>Nucleic Acids Res.</source><year>2012</year><volume>40</volume><fpage>6800</fpage><lpage>6807</lpage><pub-id pub-id-type="doi">10.1093/nar/gks321</pub-id><pub-id pub-id-type="pmid">22495932</pub-id>
</element-citation><mixed-citation id="mc-CR46" publication-type="journal">Bortolin-Cavaill&#x000e9;, M. L. &#x00026; Cavaill&#x000e9;, J. The SNORD115 (H/MBII-52) and SNORD116 (H/MBII-85) gene clusters at the imprinted Prader&#x02013;Willi locus generate canonical box C/D snoRNAs. <italic>Nucleic Acids Res.</italic><bold>40</bold>, 6800&#x02013;6807 (2012).<pub-id pub-id-type="pmid">22495932</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR47"><label>47.</label><citation-alternatives><element-citation id="ec-CR47" publication-type="journal"><person-group person-group-type="author"><name><surname>Gentry</surname><given-names>LR</given-names></name><name><surname>Martin</surname><given-names>TD</given-names></name><name><surname>Reiner</surname><given-names>DJ</given-names></name><name><surname>Der</surname><given-names>CJ</given-names></name></person-group><article-title>Ral small GTPase signaling and oncogenesis: More than just 15&#x02009;min of fame</article-title><source>Biochim. Biophys. Acta - Mol. Cell Res.</source><year>2014</year><volume>1843</volume><fpage>2976</fpage><lpage>2988</lpage><pub-id pub-id-type="doi">10.1016/j.bbamcr.2014.09.004</pub-id></element-citation><mixed-citation id="mc-CR47" publication-type="journal">Gentry, L. R., Martin, T. D., Reiner, D. J. &#x00026; Der, C. J. Ral small GTPase signaling and oncogenesis: More than just 15&#x02009;min of fame. <italic>Biochim. Biophys. Acta - Mol. Cell Res.</italic><bold>1843</bold>, 2976&#x02013;2988 (2014).</mixed-citation></citation-alternatives></ref><ref id="CR48"><label>48.</label><citation-alternatives><element-citation id="ec-CR48" publication-type="journal"><person-group person-group-type="author"><name><surname>Breckpot</surname><given-names>J</given-names></name><etal/></person-group><article-title>Copy number variation analysis in adults with catatonia confirms haploinsufficiency of SHANK3 as a predisposing factor</article-title><source>Eur. J. Med. Genet.</source><year>2016</year><volume>59</volume><fpage>436</fpage><lpage>443</lpage><pub-id pub-id-type="doi">10.1016/j.ejmg.2016.08.003</pub-id><pub-id pub-id-type="pmid">27519580</pub-id>
</element-citation><mixed-citation id="mc-CR48" publication-type="journal">Breckpot, J. et al. Copy number variation analysis in adults with catatonia confirms haploinsufficiency of SHANK3 as a predisposing factor. <italic>Eur. J. Med. Genet.</italic><bold>59</bold>, 436&#x02013;443 (2016).<pub-id pub-id-type="pmid">27519580</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR49"><label>49.</label><citation-alternatives><element-citation id="ec-CR49" publication-type="journal"><person-group person-group-type="author"><name><surname>Dhossche</surname><given-names>DM</given-names></name><name><surname>Song</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name></person-group><article-title>Is there a connection between autism, Prader-Willi syndrome, catatonia, and GABA?</article-title><source>Int. Rev. Neurobiol.</source><year>2005</year><volume>71</volume><fpage>189</fpage><lpage>216</lpage><pub-id pub-id-type="doi">10.1016/S0074-7742(05)71009-6</pub-id><pub-id pub-id-type="pmid">16512352</pub-id>
</element-citation><mixed-citation id="mc-CR49" publication-type="journal">Dhossche, D. M., Song, Y. &#x00026; Liu, Y. Is there a connection between autism, Prader-Willi syndrome, catatonia, and GABA? <italic>Int. Rev. Neurobiol.</italic><bold>71</bold>, 189&#x02013;216 (2005).<pub-id pub-id-type="pmid">16512352</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR50"><label>50.</label><citation-alternatives><element-citation id="ec-CR50" publication-type="journal"><person-group person-group-type="author"><name><surname>Chagnon</surname><given-names>YC</given-names></name></person-group><article-title>Shared susceptibility region on chromosome 15 between autism and catatonia</article-title><source>Int. Rev. Neurobiol.</source><year>2006</year><volume>72</volume><fpage>165</fpage><lpage>178</lpage><pub-id pub-id-type="doi">10.1016/S0074-7742(05)72010-9</pub-id><pub-id pub-id-type="pmid">16697297</pub-id>
</element-citation><mixed-citation id="mc-CR50" publication-type="journal">Chagnon, Y. C. Shared susceptibility region on chromosome 15 between autism and catatonia. <italic>Int. Rev. Neurobiol.</italic><bold>72</bold>, 165&#x02013;178 (2006).<pub-id pub-id-type="pmid">16697297</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR51"><label>51.</label><citation-alternatives><element-citation id="ec-CR51" publication-type="journal"><person-group person-group-type="author"><name><surname>Sohal</surname><given-names>VS</given-names></name><name><surname>Rubenstein</surname><given-names>JLR</given-names></name></person-group><article-title>Excitation-inhibition balance as a framework for investigating mechanisms in neuropsychiatric disorders</article-title><source>Mol. Psychiatry 2019 249</source><year>2019</year><volume>24</volume><fpage>1248</fpage><lpage>1257</lpage></element-citation><mixed-citation id="mc-CR51" publication-type="journal">Sohal, V. S. &#x00026; Rubenstein, J. L. R. Excitation-inhibition balance as a framework for investigating mechanisms in neuropsychiatric disorders. <italic>Mol. Psychiatry 2019 249</italic><bold>24</bold>, 1248&#x02013;1257 (2019).</mixed-citation></citation-alternatives></ref><ref id="CR52"><label>52.</label><citation-alternatives><element-citation id="ec-CR52" publication-type="journal"><person-group person-group-type="author"><name><surname>Parenti</surname><given-names>A</given-names></name><name><surname>Jardri</surname><given-names>R</given-names></name><name><surname>Geoffroy</surname><given-names>PA</given-names></name></person-group><article-title>How anti-NMDAR encephalitis sheds light on the mechanisms underlying catatonia: The neural excitatory/inhibitory imbalance model</article-title><source>Psychosomatics</source><year>2016</year><volume>57</volume><fpage>336</fpage><lpage>338</lpage><pub-id pub-id-type="doi">10.1016/j.psym.2016.01.007</pub-id><pub-id pub-id-type="pmid">27155123</pub-id>
</element-citation><mixed-citation id="mc-CR52" publication-type="journal">Parenti, A., Jardri, R. &#x00026; Geoffroy, P. A. How anti-NMDAR encephalitis sheds light on the mechanisms underlying catatonia: The neural excitatory/inhibitory imbalance model. <italic>Psychosomatics</italic><bold>57</bold>, 336&#x02013;338 (2016).<pub-id pub-id-type="pmid">27155123</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR53"><label>53.</label><citation-alternatives><element-citation id="ec-CR53" publication-type="journal"><person-group person-group-type="author"><name><surname>Northoff</surname><given-names>G</given-names></name><etal/></person-group><article-title>Decreased density of GABA-A receptors in the left sensorimotor cortex in akinetic catatonia: investigation of in vivo benzodiazepine receptor binding</article-title><source>J. Neurol. Neurosurg. Psychiatry</source><year>1999</year><volume>67</volume><fpage>445</fpage><lpage>450</lpage><pub-id pub-id-type="doi">10.1136/jnnp.67.4.445</pub-id><pub-id pub-id-type="pmid">10486389</pub-id>
</element-citation><mixed-citation id="mc-CR53" publication-type="journal">Northoff, G. et al. Decreased density of GABA-A receptors in the left sensorimotor cortex in akinetic catatonia: investigation of in vivo benzodiazepine receptor binding. <italic>J. Neurol. Neurosurg. Psychiatry</italic><bold>67</bold>, 445&#x02013;450 (1999).<pub-id pub-id-type="pmid">10486389</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR54"><label>54.</label><citation-alternatives><element-citation id="ec-CR54" publication-type="journal"><person-group person-group-type="author"><name><surname>Dhossche</surname><given-names>DM</given-names></name><name><surname>Stoppelbein</surname><given-names>L</given-names></name><name><surname>Rout</surname><given-names>UK</given-names></name></person-group><article-title>Etiopathogenesis of catatonia: Generalizations and working hypotheses</article-title><source>J. ECT</source><year>2010</year><volume>26</volume><fpage>253</fpage><lpage>258</lpage><pub-id pub-id-type="doi">10.1097/YCT.0b013e3181fbf96d</pub-id><pub-id pub-id-type="pmid">21076339</pub-id>
</element-citation><mixed-citation id="mc-CR54" publication-type="journal">Dhossche, D. M., Stoppelbein, L. &#x00026; Rout, U. K. Etiopathogenesis of catatonia: Generalizations and working hypotheses. <italic>J. ECT</italic><bold>26</bold>, 253&#x02013;258 (2010).<pub-id pub-id-type="pmid">21076339</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR55"><label>55.</label><citation-alternatives><element-citation id="ec-CR55" publication-type="journal"><person-group person-group-type="author"><name><surname>Boy</surname><given-names>F</given-names></name><etal/></person-group><article-title>Individual differences in subconscious motor control predicted by GABA concentration in SMA</article-title><source>Curr. Biol.</source><year>2010</year><volume>20</volume><fpage>1779</fpage><lpage>1785</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2010.09.003</pub-id><pub-id pub-id-type="pmid">20888227</pub-id>
</element-citation><mixed-citation id="mc-CR55" publication-type="journal">Boy, F. et al. Individual differences in subconscious motor control predicted by GABA concentration in SMA. <italic>Curr. Biol.</italic><bold>20</bold>, 1779&#x02013;1785 (2010).<pub-id pub-id-type="pmid">20888227</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR56"><label>56.</label><citation-alternatives><element-citation id="ec-CR56" publication-type="journal"><person-group person-group-type="author"><name><surname>de la Torre-Ubieta</surname><given-names>L</given-names></name><name><surname>Won</surname><given-names>H</given-names></name><name><surname>Stein</surname><given-names>JL</given-names></name><name><surname>Geschwind</surname><given-names>DH</given-names></name></person-group><article-title>Advancing the understanding of autism disease mechanisms through genetics</article-title><source>Nat. Med.</source><year>2016</year><volume>22</volume><fpage>345</fpage><lpage>361</lpage><pub-id pub-id-type="doi">10.1038/nm.4071</pub-id><pub-id pub-id-type="pmid">27050589</pub-id>
</element-citation><mixed-citation id="mc-CR56" publication-type="journal">de la Torre-Ubieta, L., Won, H., Stein, J. L. &#x00026; Geschwind, D. H. Advancing the understanding of autism disease mechanisms through genetics. <italic>Nat. Med.</italic><bold>22</bold>, 345&#x02013;361 (2016).<pub-id pub-id-type="pmid">27050589</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR57"><label>57.</label><mixed-citation publication-type="other">Selten, M., van Bokhoven, H. &#x00026; Kasri, N. N. Inhibitory control of the excitatory/inhibitory balance in psychiatric disorders. <italic>F1000Research</italic><bold>7</bold>, 23 (2018).</mixed-citation></ref><ref id="CR58"><label>58.</label><citation-alternatives><element-citation id="ec-CR58" publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>J</given-names></name><etal/></person-group><article-title>Shank3-mutant mice lacking exon 9 show altered excitation/inhibition balance, enhanced rearing, and spatial memory deficit</article-title><source>Front. Cell. Neurosci.</source><year>2015</year><volume>9</volume><fpage>94</fpage><pub-id pub-id-type="doi">10.3389/fncel.2015.00094</pub-id><pub-id pub-id-type="pmid">25852484</pub-id>
</element-citation><mixed-citation id="mc-CR58" publication-type="journal">Lee, J. et al. Shank3-mutant mice lacking exon 9 show altered excitation/inhibition balance, enhanced rearing, and spatial memory deficit. <italic>Front. Cell. Neurosci.</italic><bold>9</bold>, 94 (2015).<pub-id pub-id-type="pmid">25852484</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR59"><label>59.</label><citation-alternatives><element-citation id="ec-CR59" publication-type="journal"><person-group person-group-type="author"><name><surname>Bateup</surname><given-names>HS</given-names></name><etal/></person-group><article-title>Excitatory/inhibitory synaptic imbalance leads to hippocampal hyperexcitability in mouse models of tuberous sclerosis</article-title><source>Neuron</source><year>2013</year><volume>78</volume><fpage>510</fpage><lpage>522</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2013.03.017</pub-id><pub-id pub-id-type="pmid">23664616</pub-id>
</element-citation><mixed-citation id="mc-CR59" publication-type="journal">Bateup, H. S. et al. Excitatory/inhibitory synaptic imbalance leads to hippocampal hyperexcitability in mouse models of tuberous sclerosis. <italic>Neuron</italic><bold>78</bold>, 510&#x02013;522 (2013).<pub-id pub-id-type="pmid">23664616</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR60"><label>60.</label><citation-alternatives><element-citation id="ec-CR60" publication-type="journal"><person-group person-group-type="author"><name><surname>Oblak</surname><given-names>AL</given-names></name><name><surname>Gibbs</surname><given-names>TT</given-names></name><name><surname>Blatt</surname><given-names>GJ</given-names></name></person-group><article-title>Decreased GABAB receptors in the cingulate cortex and fusiform gyrus in autism</article-title><source>J. Neurochem.</source><year>2010</year><volume>114</volume><fpage>1414</fpage><lpage>1423</lpage><pub-id pub-id-type="doi">10.1111/j.1471-4159.2010.06858.x</pub-id><pub-id pub-id-type="pmid">20557420</pub-id>
</element-citation><mixed-citation id="mc-CR60" publication-type="journal">Oblak, A. L., Gibbs, T. T. &#x00026; Blatt, G. J. Decreased GABAB receptors in the cingulate cortex and fusiform gyrus in autism. <italic>J. Neurochem.</italic><bold>114</bold>, 1414&#x02013;1423 (2010).<pub-id pub-id-type="pmid">20557420</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR61"><label>61.</label><citation-alternatives><element-citation id="ec-CR61" publication-type="journal"><person-group person-group-type="author"><name><surname>Yizhar</surname><given-names>O</given-names></name><etal/></person-group><article-title>Neocortical excitation/inhibition balance in information processing and social dysfunction</article-title><source>Nature</source><year>2011</year><volume>477</volume><fpage>171</fpage><lpage>178</lpage><pub-id pub-id-type="doi">10.1038/nature10360</pub-id><pub-id pub-id-type="pmid">21796121</pub-id>
</element-citation><mixed-citation id="mc-CR61" publication-type="journal">Yizhar, O. et al. Neocortical excitation/inhibition balance in information processing and social dysfunction. <italic>Nature</italic><bold>477</bold>, 171&#x02013;178 (2011).<pub-id pub-id-type="pmid">21796121</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR62"><label>62.</label><citation-alternatives><element-citation id="ec-CR62" publication-type="journal"><person-group person-group-type="author"><name><surname>Won</surname><given-names>H</given-names></name><etal/></person-group><article-title>Autistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function</article-title><source>Nature</source><year>2012</year><volume>486</volume><fpage>261</fpage><lpage>265</lpage><pub-id pub-id-type="doi">10.1038/nature11208</pub-id><pub-id pub-id-type="pmid">22699620</pub-id>
</element-citation><mixed-citation id="mc-CR62" publication-type="journal">Won, H. et al. Autistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function. <italic>Nature</italic><bold>486</bold>, 261&#x02013;265 (2012).<pub-id pub-id-type="pmid">22699620</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR63"><label>63.</label><citation-alternatives><element-citation id="ec-CR63" publication-type="journal"><person-group person-group-type="author"><name><surname>Canitano</surname><given-names>R</given-names></name></person-group><article-title>Epilepsy in autism spectrum disorders</article-title><source>Eur. child Adolesc. psychiatry</source><year>2007</year><volume>16</volume><fpage>61</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1007/s00787-006-0563-2</pub-id><pub-id pub-id-type="pmid">16932856</pub-id>
</element-citation><mixed-citation id="mc-CR63" publication-type="journal">Canitano, R. Epilepsy in autism spectrum disorders. <italic>Eur. child Adolesc. psychiatry</italic><bold>16</bold>, 61&#x02013;66 (2007).<pub-id pub-id-type="pmid">16932856</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR64"><label>64.</label><citation-alternatives><element-citation id="ec-CR64" publication-type="journal"><person-group person-group-type="author"><name><surname>Huh</surname><given-names>JR</given-names></name><name><surname>Veiga-Fernandes</surname><given-names>H</given-names></name></person-group><article-title>Neuroimmune circuits in inter-organ communication</article-title><source>Nat. Rev. Immunol.</source><year>2020</year><volume>20</volume><fpage>217</fpage><lpage>228</lpage><pub-id pub-id-type="doi">10.1038/s41577-019-0247-z</pub-id><pub-id pub-id-type="pmid">31848462</pub-id>
</element-citation><mixed-citation id="mc-CR64" publication-type="journal">Huh, J. R. &#x00026; Veiga-Fernandes, H. Neuroimmune circuits in inter-organ communication. <italic>Nat. Rev. Immunol.</italic><bold>20</bold>, 217&#x02013;228 (2020).<pub-id pub-id-type="pmid">31848462</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR65"><label>65.</label><citation-alternatives><element-citation id="ec-CR65" publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>S</given-names></name><etal/></person-group><article-title>Family history of autoimmune diseases is associated with an increased risk of autism in children: A systematic review and meta-analysis</article-title><source>Neurosci. Biobehav. Rev.</source><year>2015</year><volume>55</volume><fpage>322</fpage><lpage>332</lpage><pub-id pub-id-type="doi">10.1016/j.neubiorev.2015.05.004</pub-id><pub-id pub-id-type="pmid">25981892</pub-id>
</element-citation><mixed-citation id="mc-CR65" publication-type="journal">Wu, S. et al. Family history of autoimmune diseases is associated with an increased risk of autism in children: A systematic review and meta-analysis. <italic>Neurosci. Biobehav. Rev.</italic><bold>55</bold>, 322&#x02013;332 (2015).<pub-id pub-id-type="pmid">25981892</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR66"><label>66.</label><citation-alternatives><element-citation id="ec-CR66" publication-type="journal"><person-group person-group-type="author"><name><surname>Rogers</surname><given-names>JP</given-names></name><name><surname>Pollak</surname><given-names>TA</given-names></name><name><surname>Blackman</surname><given-names>G</given-names></name><name><surname>David</surname><given-names>AS</given-names></name></person-group><article-title>Catatonia and the immune system: A review</article-title><source>Lancet Psychiatry</source><year>2019</year><volume>6</volume><fpage>620</fpage><lpage>630</lpage><pub-id pub-id-type="doi">10.1016/S2215-0366(19)30190-7</pub-id><pub-id pub-id-type="pmid">31196793</pub-id>
</element-citation><mixed-citation id="mc-CR66" publication-type="journal">Rogers, J. P., Pollak, T. A., Blackman, G. &#x00026; David, A. S. Catatonia and the immune system: A review. <italic>Lancet Psychiatry</italic><bold>6</bold>, 620&#x02013;630 (2019).<pub-id pub-id-type="pmid">31196793</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR67"><label>67.</label><citation-alternatives><element-citation id="ec-CR67" publication-type="journal"><person-group person-group-type="author"><name><surname>Espinola-Nadurille</surname><given-names>M</given-names></name><etal/></person-group><article-title>Catatonia in patients with anti-NMDA receptor encephalitis</article-title><source>Psychiatry Clin. Neurosci.</source><year>2019</year><volume>73</volume><fpage>574</fpage><lpage>580</lpage><pub-id pub-id-type="doi">10.1111/pcn.12867</pub-id><pub-id pub-id-type="pmid">31115962</pub-id>
</element-citation><mixed-citation id="mc-CR67" publication-type="journal">Espinola-Nadurille, M. et al. Catatonia in patients with anti-NMDA receptor encephalitis. <italic>Psychiatry Clin. Neurosci.</italic><bold>73</bold>, 574&#x02013;580 (2019).<pub-id pub-id-type="pmid">31115962</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR68"><label>68.</label><citation-alternatives><element-citation id="ec-CR68" publication-type="journal"><person-group person-group-type="author"><name><surname>Samra</surname><given-names>K</given-names></name><name><surname>Rogers</surname><given-names>J</given-names></name><name><surname>Mahdi-Rogers</surname><given-names>M</given-names></name><name><surname>Stanton</surname><given-names>B</given-names></name></person-group><article-title>Catatonia with GABAA receptor antibodies</article-title><source>Pract. Neurol.</source><year>2020</year><volume>20</volume><fpage>139</fpage><lpage>143</lpage><pub-id pub-id-type="doi">10.1136/practneurol-2019-002388</pub-id><pub-id pub-id-type="pmid">31771952</pub-id>
</element-citation><mixed-citation id="mc-CR68" publication-type="journal">Samra, K., Rogers, J., Mahdi-Rogers, M. &#x00026; Stanton, B. Catatonia with GABAA receptor antibodies. <italic>Pract. Neurol.</italic><bold>20</bold>, 139&#x02013;143 (2020).<pub-id pub-id-type="pmid">31771952</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR69"><label>69.</label><citation-alternatives><element-citation id="ec-CR69" publication-type="journal"><person-group person-group-type="author"><name><surname>Dalmau</surname><given-names>J</given-names></name><name><surname>Graus</surname><given-names>F</given-names></name></person-group><article-title>Antibody-mediated encephalitis</article-title><source>N. Engl. J. Med.</source><year>2018</year><volume>378</volume><fpage>840</fpage><lpage>851</lpage><pub-id pub-id-type="doi">10.1056/NEJMra1708712</pub-id><pub-id pub-id-type="pmid">29490181</pub-id>
</element-citation><mixed-citation id="mc-CR69" publication-type="journal">Dalmau, J. &#x00026; Graus, F. Antibody-mediated encephalitis. <italic>N. Engl. J. Med.</italic><bold>378</bold>, 840&#x02013;851 (2018).<pub-id pub-id-type="pmid">29490181</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR70"><label>70.</label><mixed-citation publication-type="other">An, X. &#x00026; Shi, X. Effects of electroconvulsive shock on neuro-immune responses: Does neuro-damage occur? <italic>Psychiatry Res</italic>. <bold>292</bold>, 113289 (2020).</mixed-citation></ref><ref id="CR71"><label>71.</label><mixed-citation publication-type="other">Goldfarb, S., Fainstein, N. &#x00026; Ben-Hur, T. Electroconvulsive stimulation attenuates chronic neuroinflammation. <italic>JCI insight</italic><bold>5</bold>, e137028 (2020).</mixed-citation></ref><ref id="CR72"><label>72.</label><citation-alternatives><element-citation id="ec-CR72" publication-type="journal"><person-group person-group-type="author"><name><surname>Edmiston</surname><given-names>E</given-names></name><name><surname>Ashwood</surname><given-names>P</given-names></name><name><surname>de Water</surname><given-names>J</given-names></name></person-group><article-title>Autoimmunity, autoantibodies, and autism spectrum disorder</article-title><source>Biol. Psychiatry</source><year>2017</year><volume>81</volume><fpage>383</fpage><lpage>390</lpage><pub-id pub-id-type="doi">10.1016/j.biopsych.2016.08.031</pub-id><pub-id pub-id-type="pmid">28340985</pub-id>
</element-citation><mixed-citation id="mc-CR72" publication-type="journal">Edmiston, E., Ashwood, P. &#x00026; de Water, J. Autoimmunity, autoantibodies, and autism spectrum disorder. <italic>Biol. Psychiatry</italic><bold>81</bold>, 383&#x02013;390 (2017).<pub-id pub-id-type="pmid">28340985</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR73"><label>73.</label><citation-alternatives><element-citation id="ec-CR73" publication-type="journal"><person-group person-group-type="author"><name><surname>Nordahl</surname><given-names>CW</given-names></name><etal/></person-group><article-title>Maternal autoantibodies are associated with abnormal brain enlargement in a subgroup of children with autism spectrum disorder</article-title><source>Brain. Behav. Immun.</source><year>2013</year><volume>30</volume><fpage>61</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1016/j.bbi.2013.01.084</pub-id><pub-id pub-id-type="pmid">23395715</pub-id>
</element-citation><mixed-citation id="mc-CR73" publication-type="journal">Nordahl, C. W. et al. Maternal autoantibodies are associated with abnormal brain enlargement in a subgroup of children with autism spectrum disorder. <italic>Brain. Behav. Immun.</italic><bold>30</bold>, 61&#x02013;65 (2013).<pub-id pub-id-type="pmid">23395715</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR74"><label>74.</label><citation-alternatives><element-citation id="ec-CR74" publication-type="journal"><person-group person-group-type="author"><name><surname>Braunschweig</surname><given-names>D</given-names></name><etal/></person-group><article-title>Behavioral correlates of maternal antibody status among children with autism</article-title><source>J. Autism Dev. Disord.</source><year>2012</year><volume>42</volume><fpage>1435</fpage><lpage>1445</lpage><pub-id pub-id-type="doi">10.1007/s10803-011-1378-7</pub-id><pub-id pub-id-type="pmid">22012245</pub-id>
</element-citation><mixed-citation id="mc-CR74" publication-type="journal">Braunschweig, D. et al. Behavioral correlates of maternal antibody status among children with autism. <italic>J. Autism Dev. Disord.</italic><bold>42</bold>, 1435&#x02013;1445 (2012).<pub-id pub-id-type="pmid">22012245</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR75"><label>75.</label><citation-alternatives><element-citation id="ec-CR75" publication-type="journal"><person-group person-group-type="author"><name><surname>Saffari</surname><given-names>A</given-names></name><etal/></person-group><article-title>RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation</article-title><source>Mol. Autism</source><year>2019</year><volume>10</volume><fpage>1</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1186/s13229-019-0285-1</pub-id><pub-id pub-id-type="pmid">30647876</pub-id>
</element-citation><mixed-citation id="mc-CR75" publication-type="journal">Saffari, A. et al. RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation. <italic>Mol. Autism</italic><bold>10</bold>, 1&#x02013;15 (2019).<pub-id pub-id-type="pmid">30647876</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR76"><label>76.</label><citation-alternatives><element-citation id="ec-CR76" publication-type="journal"><person-group person-group-type="author"><name><surname>Fagan</surname><given-names>K</given-names></name><name><surname>Crider</surname><given-names>A</given-names></name><name><surname>Ahmed</surname><given-names>AO</given-names></name><name><surname>Pillai</surname><given-names>A</given-names></name></person-group><article-title>Complement C3 expression is decreased in autism spectrum disorder subjects and contributes to behavioral deficits in rodents</article-title><source>Mol. Neuropsychiatry</source><year>2017</year><volume>3</volume><fpage>19</fpage><lpage>27</lpage><pub-id pub-id-type="pmid">28879198</pub-id>
</element-citation><mixed-citation id="mc-CR76" publication-type="journal">Fagan, K., Crider, A., Ahmed, A. O. &#x00026; Pillai, A. Complement C3 expression is decreased in autism spectrum disorder subjects and contributes to behavioral deficits in rodents. <italic>Mol. Neuropsychiatry</italic><bold>3</bold>, 19&#x02013;27 (2017).<pub-id pub-id-type="pmid">28879198</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR77"><label>77.</label><citation-alternatives><element-citation id="ec-CR77" publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>S</given-names></name><etal/></person-group><article-title>Transcriptome analysis reveals dysregulation of innate immune response genes and neuronal activity-dependent genes in autism</article-title><source>Nat. Commun.</source><year>2014</year><volume>5</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1038/ncomms6748</pub-id></element-citation><mixed-citation id="mc-CR77" publication-type="journal">Gupta, S. et al. Transcriptome analysis reveals dysregulation of innate immune response genes and neuronal activity-dependent genes in autism. <italic>Nat. Commun.</italic><bold>5</bold>, 1&#x02013;8 (2014).</mixed-citation></citation-alternatives></ref><ref id="CR78"><label>78.</label><citation-alternatives><element-citation id="ec-CR78" publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Z-X</given-names></name><etal/></person-group><article-title>Elevated protein synthesis in microglia causes autism-like synaptic and behavioral aberrations</article-title><source>Nat. Commun.</source><year>2020</year><volume>11</volume><fpage>1</fpage><lpage>17</lpage><pub-id pub-id-type="pmid">31911652</pub-id>
</element-citation><mixed-citation id="mc-CR78" publication-type="journal">Xu, Z.-X. et al. Elevated protein synthesis in microglia causes autism-like synaptic and behavioral aberrations. <italic>Nat. Commun.</italic><bold>11</bold>, 1&#x02013;17 (2020).<pub-id pub-id-type="pmid">31911652</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR79"><label>79.</label><citation-alternatives><element-citation id="ec-CR79" publication-type="journal"><person-group person-group-type="author"><name><surname>Spann</surname><given-names>MN</given-names></name><etal/></person-group><article-title>Proband and familial autoimmune diseases are associated with proband diagnosis of autism spectrum disorders</article-title><source>J. Am. Acad. Child Adolesc. Psychiatry</source><year>2019</year><volume>58</volume><fpage>496</fpage><lpage>505</lpage><pub-id pub-id-type="doi">10.1016/j.jaac.2018.09.444</pub-id><pub-id pub-id-type="pmid">30975444</pub-id>
</element-citation><mixed-citation id="mc-CR79" publication-type="journal">Spann, M. N. et al. Proband and familial autoimmune diseases are associated with proband diagnosis of autism spectrum disorders. <italic>J. Am. Acad. Child Adolesc. Psychiatry</italic><bold>58</bold>, 496&#x02013;505 (2019).<pub-id pub-id-type="pmid">30975444</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR80"><label>80.</label><mixed-citation publication-type="other">Manickam, K. et al. Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: An evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG). <italic>Genet. Med</italic>. 10.1038/s41436-021-01242-6 (2021).</mixed-citation></ref><ref id="CR81"><label>81.</label><citation-alternatives><element-citation id="ec-CR81" publication-type="journal"><person-group person-group-type="author"><name><surname>Serret</surname><given-names>S</given-names></name><etal/></person-group><article-title>Lithium as a rescue therapy for regression and catatonia features in two SHANK3 patients with autism spectrum disorder: Case reports</article-title><source>BMC Psychiatry</source><year>2015</year><volume>15</volume><fpage>107</fpage><pub-id pub-id-type="doi">10.1186/s12888-015-0490-1</pub-id><pub-id pub-id-type="pmid">25947967</pub-id>
</element-citation><mixed-citation id="mc-CR81" publication-type="journal">Serret, S. et al. Lithium as a rescue therapy for regression and catatonia features in two SHANK3 patients with autism spectrum disorder: Case reports. <italic>BMC Psychiatry</italic><bold>15</bold>, 107 (2015).<pub-id pub-id-type="pmid">25947967</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR82"><label>82.</label><mixed-citation publication-type="other">Bey, A. L. et al. Subacute neuropsychiatric syndrome in girls with SHANK3 mutations responds to immunomodulation. <italic>Pediatrics</italic><bold>145</bold>, e20191490 (2020).</mixed-citation></ref><ref id="CR83"><label>83.</label><citation-alternatives><element-citation id="ec-CR83" publication-type="journal"><person-group person-group-type="author"><name><surname>Dimmock</surname><given-names>DP</given-names></name><etal/></person-group><article-title>An RCT of rapid genomic sequencing among seriously Ill infants results in high clinical utility, changes in management, and low perceived harm</article-title><source>Am. J. Hum. Genet.</source><year>2020</year><volume>107</volume><fpage>942</fpage><lpage>952</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2020.10.003</pub-id><pub-id pub-id-type="pmid">33157007</pub-id>
</element-citation><mixed-citation id="mc-CR83" publication-type="journal">Dimmock, D. P. et al. An RCT of rapid genomic sequencing among seriously Ill infants results in high clinical utility, changes in management, and low perceived harm. <italic>Am. J. Hum. Genet.</italic><bold>107</bold>, 942&#x02013;952 (2020).<pub-id pub-id-type="pmid">33157007</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR84"><label>84.</label><mixed-citation publication-type="other">Nurnberger, J. I. et al. What should a psychiatrist know about genetics? Review and recommendations from the residency education committee of the international society of psychiatric genetics. <italic>J. Clin. Psychiatry</italic><bold>80</bold>, 17nr12046 (2019).</mixed-citation></ref><ref id="CR85"><label>85.</label><citation-alternatives><element-citation id="ec-CR85" publication-type="journal"><person-group person-group-type="author"><name><surname>Moldovan</surname><given-names>R</given-names></name><name><surname>Pintea</surname><given-names>S</given-names></name><name><surname>Austin</surname><given-names>J</given-names></name></person-group><article-title>The efficacy of genetic counseling for psychiatric disorders: A meta-analysis</article-title><source>J. Genet. Couns.</source><year>2017</year><volume>26</volume><fpage>1341</fpage><lpage>1347</lpage><pub-id pub-id-type="doi">10.1007/s10897-017-0113-8</pub-id><pub-id pub-id-type="pmid">28616830</pub-id>
</element-citation><mixed-citation id="mc-CR85" publication-type="journal">Moldovan, R., Pintea, S. &#x00026; Austin, J. The efficacy of genetic counseling for psychiatric disorders: A meta-analysis. <italic>J. Genet. Couns.</italic><bold>26</bold>, 1341&#x02013;1347 (2017).<pub-id pub-id-type="pmid">28616830</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR86"><label>86.</label><citation-alternatives><element-citation id="ec-CR86" publication-type="journal"><person-group person-group-type="author"><name><surname>Vorderw&#x000fc;lbecke</surname><given-names>BJ</given-names></name><etal/></person-group><article-title>Long-term outcome in adolescent-onset generalized genetic epilepsies</article-title><source>Epilepsia</source><year>2017</year><volume>58</volume><fpage>1244</fpage><lpage>1250</lpage><pub-id pub-id-type="doi">10.1111/epi.13761</pub-id><pub-id pub-id-type="pmid">28464258</pub-id>
</element-citation><mixed-citation id="mc-CR86" publication-type="journal">Vorderw&#x000fc;lbecke, B. J. et al. Long-term outcome in adolescent-onset generalized genetic epilepsies. <italic>Epilepsia</italic><bold>58</bold>, 1244&#x02013;1250 (2017).<pub-id pub-id-type="pmid">28464258</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR87"><label>87.</label><citation-alternatives><element-citation id="ec-CR87" publication-type="journal"><person-group person-group-type="author"><name><surname>Lancaster</surname><given-names>E</given-names></name></person-group><article-title>The diagnosis and treatment of autoimmune encephalitis</article-title><source>J. Clin. Neurol.</source><year>2016</year><volume>12</volume><fpage>1</fpage><pub-id pub-id-type="doi">10.3988/jcn.2016.12.1.1</pub-id><pub-id pub-id-type="pmid">26754777</pub-id>
</element-citation><mixed-citation id="mc-CR87" publication-type="journal">Lancaster, E. The diagnosis and treatment of autoimmune encephalitis. <italic>J. Clin. Neurol.</italic><bold>12</bold>, 1 (2016).<pub-id pub-id-type="pmid">26754777</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR88"><label>88.</label><citation-alternatives><element-citation id="ec-CR88" publication-type="journal"><person-group person-group-type="author"><name><surname>Abboud</surname><given-names>H</given-names></name><etal/></person-group><article-title>Autoimmune encephalitis: Proposed recommendations for symptomatic and long-term management</article-title><source>J. Neurol. Neurosurg. Psychiatry</source><year>2021</year><volume>92</volume><fpage>897</fpage><lpage>907</lpage><pub-id pub-id-type="doi">10.1136/jnnp-2020-325302</pub-id><pub-id pub-id-type="pmid">33649021</pub-id>
</element-citation><mixed-citation id="mc-CR88" publication-type="journal">Abboud, H. et al. Autoimmune encephalitis: Proposed recommendations for symptomatic and long-term management. <italic>J. Neurol. Neurosurg. Psychiatry</italic><bold>92</bold>, 897&#x02013;907 (2021).<pub-id pub-id-type="pmid">33649021</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR89"><label>89.</label><citation-alternatives><element-citation id="ec-CR89" publication-type="journal"><person-group person-group-type="author"><name><surname>Zuliani</surname><given-names>L</given-names></name><etal/></person-group><article-title>Management of antibody-mediated autoimmune encephalitis in adults and children: Literature review and consensus-based practical recommendations</article-title><source>Neurol. Sci.</source><year>2019</year><volume>40</volume><fpage>2017</fpage><lpage>2030</lpage><pub-id pub-id-type="doi">10.1007/s10072-019-03930-3</pub-id><pub-id pub-id-type="pmid">31161339</pub-id>
</element-citation><mixed-citation id="mc-CR89" publication-type="journal">Zuliani, L. et al. Management of antibody-mediated autoimmune encephalitis in adults and children: Literature review and consensus-based practical recommendations. <italic>Neurol. Sci.</italic><bold>40</bold>, 2017&#x02013;2030 (2019).<pub-id pub-id-type="pmid">31161339</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR90"><label>90.</label><citation-alternatives><element-citation id="ec-CR90" publication-type="journal"><person-group person-group-type="author"><name><surname>Gultekin</surname><given-names>SH</given-names></name><etal/></person-group><article-title>Paraneoplastic limbic encephalitis: Neurological symptoms, immunological findings and tumour association in 50 patients</article-title><source>Brain</source><year>2000</year><volume>123</volume><fpage>1481</fpage><lpage>1494</lpage><pub-id pub-id-type="doi">10.1093/brain/123.7.1481</pub-id><pub-id pub-id-type="pmid">10869059</pub-id>
</element-citation><mixed-citation id="mc-CR90" publication-type="journal">Gultekin, S. H. et al. Paraneoplastic limbic encephalitis: Neurological symptoms, immunological findings and tumour association in 50 patients. <italic>Brain</italic><bold>123</bold>, 1481&#x02013;1494 (2000).<pub-id pub-id-type="pmid">10869059</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR91"><label>91.</label><citation-alternatives><element-citation id="ec-CR91" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>F</given-names></name><etal/></person-group><article-title>Minocycline and risperidone prevent microglia activation and rescue behavioral deficits induced by neonatal intrahippocampal injection of lipopolysaccharide in rats</article-title><source>PLoS One</source><year>2014</year><volume>9</volume><fpage>e93966</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0093966</pub-id><pub-id pub-id-type="pmid">24705495</pub-id>
</element-citation><mixed-citation id="mc-CR91" publication-type="journal">Zhu, F. et al. Minocycline and risperidone prevent microglia activation and rescue behavioral deficits induced by neonatal intrahippocampal injection of lipopolysaccharide in rats. <italic>PLoS One</italic><bold>9</bold>, e93966 (2014).<pub-id pub-id-type="pmid">24705495</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR92"><label>92.</label><citation-alternatives><element-citation id="ec-CR92" publication-type="journal"><person-group person-group-type="author"><name><surname>Boontanrart</surname><given-names>M</given-names></name><name><surname>Hall</surname><given-names>SD</given-names></name><name><surname>Spanier</surname><given-names>JA</given-names></name><name><surname>Hayes</surname><given-names>CE</given-names></name><name><surname>Olson</surname><given-names>JK</given-names></name></person-group><article-title>Vitamin D3 alters microglia immune activation by an IL-10 dependent SOCS3 mechanism</article-title><source>J. Neuroimmunol.</source><year>2016</year><volume>292</volume><fpage>126</fpage><lpage>136</lpage><pub-id pub-id-type="doi">10.1016/j.jneuroim.2016.01.015</pub-id><pub-id pub-id-type="pmid">26943970</pub-id>
</element-citation><mixed-citation id="mc-CR92" publication-type="journal">Boontanrart, M., Hall, S. D., Spanier, J. A., Hayes, C. E. &#x00026; Olson, J. K. Vitamin D3 alters microglia immune activation by an IL-10 dependent SOCS3 mechanism. <italic>J. Neuroimmunol.</italic><bold>292</bold>, 126&#x02013;136 (2016).<pub-id pub-id-type="pmid">26943970</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR93"><label>93.</label><citation-alternatives><element-citation id="ec-CR93" publication-type="journal"><person-group person-group-type="author"><name><surname>Vener</surname><given-names>SM</given-names></name><name><surname>Wichnick-Gillis</surname><given-names>AM</given-names></name><name><surname>Badala</surname><given-names>D</given-names></name><name><surname>Poulson</surname><given-names>CL</given-names></name></person-group><article-title>Increasing behavior incompatible with catatonia in a young adolescent girl with autism spectrum disorder</article-title><source>Res. Autism Spectr. Disord.</source><year>2019</year><volume>57</volume><fpage>7</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1016/j.rasd.2018.09.006</pub-id></element-citation><mixed-citation id="mc-CR93" publication-type="journal">Vener, S. M., Wichnick-Gillis, A. M., Badala, D. &#x00026; Poulson, C. L. Increasing behavior incompatible with catatonia in a young adolescent girl with autism spectrum disorder. <italic>Res. Autism Spectr. Disord.</italic><bold>57</bold>, 7&#x02013;18 (2019).</mixed-citation></citation-alternatives></ref><ref id="CR94"><label>94.</label><citation-alternatives><element-citation id="ec-CR94" publication-type="journal"><person-group person-group-type="author"><name><surname>Vener</surname><given-names>SM</given-names></name><name><surname>Gillis</surname><given-names>AM</given-names></name><name><surname>Poulson</surname><given-names>CL</given-names></name></person-group><article-title>Increasing verbal behavior in a young adolescent girl with catatonia and autism spectrum disorder</article-title><source>J. Autism Dev. Disord.</source><year>2021</year><volume>51</volume><fpage>3857</fpage><lpage>3867</lpage><pub-id pub-id-type="doi">10.1007/s10803-020-04843-3</pub-id><pub-id pub-id-type="pmid">33387239</pub-id>
</element-citation><mixed-citation id="mc-CR94" publication-type="journal">Vener, S. M., Gillis, A. M. &#x00026; Poulson, C. L. Increasing verbal behavior in a young adolescent girl with catatonia and autism spectrum disorder. <italic>J. Autism Dev. Disord.</italic><bold>51</bold>, 3857&#x02013;3867 (2021).<pub-id pub-id-type="pmid">33387239</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR95"><label>95.</label><citation-alternatives><element-citation id="ec-CR95" publication-type="journal"><person-group person-group-type="author"><name><surname>Dhossche</surname><given-names>DM</given-names></name><name><surname>Shah</surname><given-names>A</given-names></name><name><surname>Wing</surname><given-names>L</given-names></name></person-group><article-title>Blueprints for the assessment, treatment, and future study of catatonia in autism spectrum disorders</article-title><source>Int. Rev. Neurobiol.</source><year>2006</year><volume>72</volume><fpage>267</fpage><lpage>284</lpage><pub-id pub-id-type="doi">10.1016/S0074-7742(05)72016-X</pub-id><pub-id pub-id-type="pmid">16697303</pub-id>
</element-citation><mixed-citation id="mc-CR95" publication-type="journal">Dhossche, D. M., Shah, A. &#x00026; Wing, L. Blueprints for the assessment, treatment, and future study of catatonia in autism spectrum disorders. <italic>Int. Rev. Neurobiol.</italic><bold>72</bold>, 267&#x02013;284 (2006).<pub-id pub-id-type="pmid">16697303</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR96"><label>96.</label><citation-alternatives><element-citation id="ec-CR96" publication-type="journal"><person-group person-group-type="author"><name><surname>Raffin</surname><given-names>M</given-names></name><etal/></person-group><article-title>Treatment use in a prospective naturalistic cohort of children and adolescents with catatonia</article-title><source>Eur. Child Adolesc. Psychiatry</source><year>2015</year><volume>24</volume><fpage>441</fpage><lpage>449</lpage><pub-id pub-id-type="doi">10.1007/s00787-014-0595-y</pub-id><pub-id pub-id-type="pmid">25159089</pub-id>
</element-citation><mixed-citation id="mc-CR96" publication-type="journal">Raffin, M. et al. Treatment use in a prospective naturalistic cohort of children and adolescents with catatonia. <italic>Eur. Child Adolesc. Psychiatry</italic><bold>24</bold>, 441&#x02013;449 (2015).<pub-id pub-id-type="pmid">25159089</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR97"><label>97.</label><mixed-citation publication-type="other">Fink, M. &#x00026; Taylor, M. A. <italic>Catatonia: A Clinician&#x02019;s Guide to Diagnosis and Treatment</italic> (Cambridge University Press, 2006).</mixed-citation></ref><ref id="CR98"><label>98.</label><mixed-citation publication-type="other">Egger, J. I. M., Verhoeven, W. M. A., Groenendijk-Reijenga, R. &#x00026; Kant, S. G. Phelan-McDermid syndrome due to SHANK3 mutation in an intellectually disabled adult male: Successful treatment with lithium. <italic>BMJ Case Rep</italic>. <bold>2017</bold>, bcr2017220778 (2017).</mixed-citation></ref><ref id="CR99"><label>99.</label><citation-alternatives><element-citation id="ec-CR99" publication-type="journal"><person-group person-group-type="author"><name><surname>Weder</surname><given-names>ND</given-names></name><name><surname>Muralee</surname><given-names>S</given-names></name><name><surname>Penland</surname><given-names>H</given-names></name><name><surname>Tampi</surname><given-names>RR</given-names></name></person-group><article-title>Catatonia: A review</article-title><source>Ann. Clin. Psychiatry</source><year>2008</year><volume>20</volume><fpage>97</fpage><lpage>107</lpage><pub-id pub-id-type="doi">10.1080/10401230802017092</pub-id><pub-id pub-id-type="pmid">18568581</pub-id>
</element-citation><mixed-citation id="mc-CR99" publication-type="journal">Weder, N. D., Muralee, S., Penland, H. &#x00026; Tampi, R. R. Catatonia: A review. <italic>Ann. Clin. Psychiatry</italic><bold>20</bold>, 97&#x02013;107 (2008).<pub-id pub-id-type="pmid">18568581</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR100"><label>100.</label><citation-alternatives><element-citation id="ec-CR100" publication-type="journal"><person-group person-group-type="author"><name><surname>Thuppal</surname><given-names>M</given-names></name><name><surname>Fink</surname><given-names>M</given-names></name></person-group><article-title>Electroconvulsive therapy and mental retardation</article-title><source>J. ECT</source><year>1999</year><volume>15</volume><fpage>140</fpage><lpage>149</lpage><pub-id pub-id-type="doi">10.1097/00124509-199906000-00005</pub-id><pub-id pub-id-type="pmid">10378153</pub-id>
</element-citation><mixed-citation id="mc-CR100" publication-type="journal">Thuppal, M. &#x00026; Fink, M. Electroconvulsive therapy and mental retardation. <italic>J. ECT</italic><bold>15</bold>, 140&#x02013;149 (1999).<pub-id pub-id-type="pmid">10378153</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR101"><label>101.</label><citation-alternatives><element-citation id="ec-CR101" publication-type="journal"><person-group person-group-type="author"><name><surname>Wachtel</surname><given-names>LE</given-names></name><etal/></person-group><article-title>ECT for self-injury in an autistic boy</article-title><source>Eur. Child Adolesc. Psychiatry</source><year>2009</year><volume>18</volume><fpage>458</fpage><lpage>463</lpage><pub-id pub-id-type="doi">10.1007/s00787-009-0754-8</pub-id><pub-id pub-id-type="pmid">19198918</pub-id>
</element-citation><mixed-citation id="mc-CR101" publication-type="journal">Wachtel, L. E. et al. ECT for self-injury in an autistic boy. <italic>Eur. Child Adolesc. Psychiatry</italic><bold>18</bold>, 458&#x02013;463 (2009).<pub-id pub-id-type="pmid">19198918</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR102"><label>102.</label><citation-alternatives><element-citation id="ec-CR102" publication-type="journal"><person-group person-group-type="author"><name><surname>Dimmock</surname><given-names>D</given-names></name><etal/></person-group><article-title>Project baby bear: Rapid precision care incorporating rWGS in 5 California children&#x02019;s hospitals demonstrates improved clinical outcomes and reduced costs of care</article-title><source>Am. J. Hum. Genet.</source><year>2021</year><volume>108</volume><fpage>1231</fpage><lpage>1238</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2021.05.008</pub-id><pub-id pub-id-type="pmid">34089648</pub-id>
</element-citation><mixed-citation id="mc-CR102" publication-type="journal">Dimmock, D. et al. Project baby bear: Rapid precision care incorporating rWGS in 5 California children&#x02019;s hospitals demonstrates improved clinical outcomes and reduced costs of care. <italic>Am. J. Hum. Genet.</italic><bold>108</bold>, 1231&#x02013;1238 (2021).<pub-id pub-id-type="pmid">34089648</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR103"><label>103.</label><citation-alternatives><element-citation id="ec-CR103" publication-type="journal"><person-group person-group-type="author"><name><surname>Sanders</surname><given-names>SJ</given-names></name><etal/></person-group><article-title>Insights into autism spectrum disorder genomic architecture and biology from 71 risk Loci</article-title><source>Neuron</source><year>2015</year><volume>87</volume><fpage>1215</fpage><lpage>1233</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2015.09.016</pub-id><pub-id pub-id-type="pmid">26402605</pub-id>
</element-citation><mixed-citation id="mc-CR103" publication-type="journal">Sanders, S. J. et al. Insights into autism spectrum disorder genomic architecture and biology from 71 risk Loci. <italic>Neuron</italic><bold>87</bold>, 1215&#x02013;1233 (2015).<pub-id pub-id-type="pmid">26402605</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR104"><label>104.</label><citation-alternatives><element-citation id="ec-CR104" publication-type="journal"><person-group person-group-type="author"><name><surname>Chaby</surname><given-names>LE</given-names></name><etal/></person-group><article-title>Repeated stress exposure in mid-adolescence attenuates behavioral, noradrenergic, and epigenetic effects of trauma-like stress in early adult male rats</article-title><source>Sci. Rep.</source><year>2020</year><volume>10</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1038/s41598-020-74481-3</pub-id><pub-id pub-id-type="pmid">31913322</pub-id>
</element-citation><mixed-citation id="mc-CR104" publication-type="journal">Chaby, L. E. et al. Repeated stress exposure in mid-adolescence attenuates behavioral, noradrenergic, and epigenetic effects of trauma-like stress in early adult male rats. <italic>Sci. Rep.</italic><bold>10</bold>, 1&#x02013;11 (2020).<pub-id pub-id-type="pmid">31913322</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR105"><label>105.</label><citation-alternatives><element-citation id="ec-CR105" publication-type="journal"><person-group person-group-type="author"><name><surname>Kelley</surname><given-names>KW</given-names></name><name><surname>Pa&#x00219;ca</surname><given-names>SP</given-names></name></person-group><article-title>Human brain organogenesis: Toward a cellular understanding of development and disease</article-title><source>Cell</source><year>2022</year><volume>185</volume><fpage>42</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2021.10.003</pub-id><pub-id pub-id-type="pmid">34774127</pub-id>
</element-citation><mixed-citation id="mc-CR105" publication-type="journal">Kelley, K. W. &#x00026; Pa&#x00219;ca, S. P. Human brain organogenesis: Toward a cellular understanding of development and disease. <italic>Cell</italic><bold>185</bold>, 42&#x02013;61 (2022).<pub-id pub-id-type="pmid">34774127</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR106"><label>106.</label><citation-alternatives><element-citation id="ec-CR106" publication-type="journal"><person-group person-group-type="author"><name><surname>Quilliam</surname><given-names>R</given-names></name><name><surname>Quilliam</surname><given-names>S</given-names></name><name><surname>Turnbull</surname><given-names>M</given-names></name><name><surname>Parkinson</surname><given-names>S</given-names></name><name><surname>Oligbu</surname><given-names>G</given-names></name></person-group><article-title>Catatonia as a presentation of autism in a child: A case report</article-title><source>AIMS Neurosci.</source><year>2020</year><volume>7</volume><fpage>327</fpage><pub-id pub-id-type="doi">10.3934/Neuroscience.2020019</pub-id><pub-id pub-id-type="pmid">32995490</pub-id>
</element-citation><mixed-citation id="mc-CR106" publication-type="journal">Quilliam, R., Quilliam, S., Turnbull, M., Parkinson, S. &#x00026; Oligbu, G. Catatonia as a presentation of autism in a child: A case report. <italic>AIMS Neurosci.</italic><bold>7</bold>, 327 (2020).<pub-id pub-id-type="pmid">32995490</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR107"><label>107.</label><citation-alternatives><element-citation id="ec-CR107" publication-type="journal"><person-group person-group-type="author"><name><surname>Withane</surname><given-names>N</given-names></name><name><surname>Dhossche</surname><given-names>DM</given-names></name></person-group><article-title>Electroconvulsive treatment for catatonia in autism spectrum disorders</article-title><source>Child Adolesc. Psychiatr. Clin. N Am.</source><year>2019</year><volume>28</volume><fpage>101</fpage><lpage>110</lpage><pub-id pub-id-type="doi">10.1016/j.chc.2018.07.006</pub-id><pub-id pub-id-type="pmid">30389070</pub-id>
</element-citation><mixed-citation id="mc-CR107" publication-type="journal">Withane, N. &#x00026; Dhossche, D. M. Electroconvulsive treatment for catatonia in autism spectrum disorders. <italic>Child Adolesc. Psychiatr. Clin. N Am.</italic><bold>28</bold>, 101&#x02013;110 (2019).<pub-id pub-id-type="pmid">30389070</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR108"><label>108.</label><citation-alternatives><element-citation id="ec-CR108" publication-type="journal"><person-group person-group-type="author"><name><surname>Quigley</surname><given-names>J</given-names></name><name><surname>Lommel</surname><given-names>KM</given-names></name><name><surname>Coffey</surname><given-names>B</given-names></name></person-group><article-title>Catatonia in an adolescent with Asperger&#x02019;s disorder</article-title><source>J. Child Adolesc. Psychopharmacol.</source><year>2009</year><volume>19</volume><fpage>93</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.1089/cap.2009.1913</pub-id><pub-id pub-id-type="pmid">19232028</pub-id>
</element-citation><mixed-citation id="mc-CR108" publication-type="journal">Quigley, J., Lommel, K. M. &#x00026; Coffey, B. Catatonia in an adolescent with Asperger&#x02019;s disorder. <italic>J. Child Adolesc. Psychopharmacol.</italic><bold>19</bold>, 93&#x02013;96 (2009).<pub-id pub-id-type="pmid">19232028</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR109"><label>109.</label><citation-alternatives><element-citation id="ec-CR109" publication-type="journal"><person-group person-group-type="author"><name><surname>Wachtel</surname><given-names>LE</given-names></name><name><surname>Kahng</surname><given-names>SW</given-names></name><name><surname>Dhossche</surname><given-names>DM</given-names></name><name><surname>Cascella</surname><given-names>N</given-names></name><name><surname>Reti</surname><given-names>IM</given-names></name></person-group><article-title>ECT for catatonia in an autistic girl</article-title><source>Am. J. Psychiatry</source><year>2008</year><volume>165</volume><fpage>329</fpage><lpage>333</lpage><pub-id pub-id-type="doi">10.1176/appi.ajp.2007.07081246</pub-id><pub-id pub-id-type="pmid">18316431</pub-id>
</element-citation><mixed-citation id="mc-CR109" publication-type="journal">Wachtel, L. E., Kahng, S. W., Dhossche, D. M., Cascella, N. &#x00026; Reti, I. M. ECT for catatonia in an autistic girl. <italic>Am. J. Psychiatry</italic><bold>165</bold>, 329&#x02013;333 (2008).<pub-id pub-id-type="pmid">18316431</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR110"><label>110.</label><citation-alternatives><element-citation id="ec-CR110" publication-type="journal"><person-group person-group-type="author"><name><surname>Wachtel</surname><given-names>LE</given-names></name><name><surname>Griffin</surname><given-names>MM</given-names></name><name><surname>Dhossche</surname><given-names>DM</given-names></name><name><surname>Reti</surname><given-names>IM</given-names></name></person-group><article-title>Brief report: Electroconvulsive therapy for malignant catatonia in an autistic adolescent</article-title><source>Autism</source><year>2010</year><volume>14</volume><fpage>349</fpage><lpage>358</lpage><pub-id pub-id-type="doi">10.1177/1362361309350135</pub-id><pub-id pub-id-type="pmid">20591959</pub-id>
</element-citation><mixed-citation id="mc-CR110" publication-type="journal">Wachtel, L. E., Griffin, M. M., Dhossche, D. M. &#x00026; Reti, I. M. Brief report: Electroconvulsive therapy for malignant catatonia in an autistic adolescent. <italic>Autism</italic><bold>14</bold>, 349&#x02013;358 (2010).<pub-id pub-id-type="pmid">20591959</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR111"><label>111.</label><citation-alternatives><element-citation id="ec-CR111" publication-type="journal"><person-group person-group-type="author"><name><surname>Haq</surname><given-names>AU</given-names></name><name><surname>Ghaziuddin</surname><given-names>N</given-names></name></person-group><article-title>Maintenance electroconvulsive therapy for aggression and self-injurious behavior in two adolescents with autism and catatonia</article-title><source>J. Neuropsychiatry Clin. Neurosci.</source><year>2014</year><volume>26</volume><fpage>64</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1176/appi.neuropsych.12110284</pub-id><pub-id pub-id-type="pmid">24515677</pub-id>
</element-citation><mixed-citation id="mc-CR111" publication-type="journal">Haq, A. U. &#x00026; Ghaziuddin, N. Maintenance electroconvulsive therapy for aggression and self-injurious behavior in two adolescents with autism and catatonia. <italic>J. Neuropsychiatry Clin. Neurosci.</italic><bold>26</bold>, 64&#x02013;72 (2014).<pub-id pub-id-type="pmid">24515677</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR112"><label>112.</label><citation-alternatives><element-citation id="ec-CR112" publication-type="journal"><person-group person-group-type="author"><name><surname>Vorstman</surname><given-names>JAS</given-names></name><etal/></person-group><article-title>Autism genetics: Opportunities and challenges for clinical translation</article-title><source>Nat. Rev. Genet.</source><year>2017</year><volume>18</volume><fpage>362</fpage><lpage>376</lpage><pub-id pub-id-type="doi">10.1038/nrg.2017.4</pub-id><pub-id pub-id-type="pmid">28260791</pub-id>
</element-citation><mixed-citation id="mc-CR112" publication-type="journal">Vorstman, J. A. S. et al. Autism genetics: Opportunities and challenges for clinical translation. <italic>Nat. Rev. Genet.</italic><bold>18</bold>, 362&#x02013;376 (2017).<pub-id pub-id-type="pmid">28260791</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR113"><label>113.</label><citation-alternatives><element-citation id="ec-CR113" publication-type="journal"><person-group person-group-type="author"><name><surname>Consoli</surname><given-names>A</given-names></name><etal/></person-group><article-title>Medical and developmental risk factors of catatonia in children and adolescents: A prospective case-control study</article-title><source>Schizophr. Res.</source><year>2012</year><volume>137</volume><fpage>151</fpage><lpage>158</lpage><pub-id pub-id-type="doi">10.1016/j.schres.2012.02.012</pub-id><pub-id pub-id-type="pmid">22401837</pub-id>
</element-citation><mixed-citation id="mc-CR113" publication-type="journal">Consoli, A. et al. Medical and developmental risk factors of catatonia in children and adolescents: A prospective case-control study. <italic>Schizophr. Res.</italic><bold>137</bold>, 151&#x02013;158 (2012).<pub-id pub-id-type="pmid">22401837</pub-id>
</mixed-citation></citation-alternatives></ref></ref-list></back></article>